image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
c64bbc5383760f0690f12a20d9f4fb13fa76fe84836a4fd4c220e5c88f7d4003.png | complex | <table><tr><td>Activities</td><td>V1</td><td>V2</td><td>V3</td><td>V4</td><td>V5</td><td>V6</td><td>Recall (%)</td></tr><tr><td>V1</td><td>92</td><td>4</td><td>2</td><td>3</td><td>0</td><td>1</td><td>90.20</td></tr><tr><td>V2</td><td>1</td><td>27</td><td>0</td><td>0</td><td>0</td><td>0</td><td>96.43</td></tr><tr><td>V3... | <table><tr><td>Activities</td><td>V1</td><td>V2</td><td>V3</td><td>V4</td><td>V5</td><td>V6</td><td>Recall (%)</td></tr><tr><td>V1</td><td>92</td><td>4</td><td>2</td><td>3</td><td>0</td><td>1</td><td>90.20</td></tr><tr><td>V2</td><td>1</td><td>27</td><td>0</td><td>0</td><td>0</td><td>0</td><td>96.43</td></tr><tr><td>V3... | <table><tr><td>V6</td><td>0</td><td>0</td><td>1</td><td>1</td><td>0</td><td>16</td><td>88.89</td></tr><tr><td>Precision (%)</td><td>92.93</td><td>87.10</td><td>71.43</td><td>93.75</td><td>94.74</td><td>84.21</td><td></td></tr><tr><td>Accuracy (%)</td><td colspan="7">90.94</td></tr></table> |
86c422f5c33f9da8e9b4a0c970b18a285580c5389e41ff2c0159f458ec3c2555.png | simple | <table><tr><td>Chromosome (potato)</td><td>Tomato</td><td>Citation<sup>1</sup></td></tr><tr><td>2</td><td>2 L inversion</td><td>a</td></tr><tr><td>3</td><td>Translocation</td><td>b</td></tr><tr><td>5</td><td>5S inversion</td><td>a, c, d, e, f</td></tr><tr><td>6</td><td>6S inversion</td><td>a, g</td></tr><tr><td>9</td><... | <table><tr><td>Chromosome (potato)</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>9</td></tr><tr><td>10</td></tr><tr><td>11</td></tr><tr><td>12</td></tr></table> | <table><tr><td>Tomato</td><td>Citation1</td></tr><tr><td>2 L inversion</td><td>a</td></tr><tr><td>Translocation</td><td>b</td></tr><tr><td>5S inversion</td><td>a, c, d, e, f</td></tr><tr><td>6S inversion</td><td>a, g</td></tr><tr><td>9S inversion</td><td>a, c, d, f</td></tr><tr><td>10 L inversion</td><td>a, c, d, f</td... |
8b34922a28d3886711a2583279be12498d0282798a10ce4c8d99aa35e3122b07.png | complex | <table><tr><td> </td><td colspan="7">Age group</td></tr><tr><td>Variables</td><td>G<sub>50-54</sub> n = 32</td><td>G<sub>55-59 </sub>n = 56</td><td>G<sub>60-64 </sub>n = 112</td><td>G<sub>65-69 </sub>n = 151</td><td>G<sub>70-74 </sub>n = 126</td><td>G<sub>75-79 </sub>n = 57</td><td>G<sub>80+ </sub>n = 22</td></tr><tr><... | <table><tr><td></td><td colspan="7">Age group</td></tr><tr><td>Variables</td><td>G50-54 n = 32</td><td>G55-59 n = 56</td><td>G60-64 n = 112</td><td>G65-69 n = 151</td><td>G70-74 n = 126</td><td>G75-79 n = 57</td><td>G80+ n = 22</td></tr><tr><td>Age, years</td><td>52.8 (1.3)</td><td>57.6 (1.6)</td><td>62.8 (1.5)</td><td... | <table><tr><td>Lower leg length, m</td><td>0.339 (0.018)</td><td>0.341 (0.017)</td><td>0.335 (0.017)</td><td>0.333 (0.017)</td><td>0.334 (0.018)</td><td>0.328 (0.016)</td><td>0.328 (0.015)</td></tr><tr><td>Body mass, kg</td><td>53.8 (6.1)</td><td>55.7 (7.2)</td><td>54.2 (6.5)</td><td>53.4 (6.9)</td><td>52.3 (6.9)</td><... |
4d4739132189b6a64f5dd07367e40fce5f85afc92c18106bf3d624a189fb62b6.png | complex | <table><tr><td>Buffer Radius (m)</td><td colspan="6">Number of children within buffer zone</td><td colspan="3">Comparison measures</td></tr><tr><td></td><td>Parcels</td><td>Street</td><td>Parcels yes/Street yes</td><td>Parcels yes/Street no</td><td>Parcel no/Street yes</td><td>Parcel no/Street no</td><td>Sensitivity (%... | <table><tr><td>Buffer Radius (m)</td><td colspan="6">Number of children within buffer zone</td><td colspan="3">Comparison measures</td></tr><tr><td></td><td>Parcels</td><td>Street</td><td>Parcels yes/Street yes</td><td>Parcels yes/Street no</td><td>Parcel no/Street yes</td><td>Parcel no/Street no</td><td>Sensitivity (%... | <table><tr><td>50 meters</td><td>391</td><td>1413</td><td>151</td><td>240</td><td>1262</td><td>103212</td><td>39</td><td>99</td><td>0.28 (0.25 – 0.31)</td></tr><tr><td>100 meters</td><td>2090</td><td>2851</td><td>1392</td><td>698</td><td>1459</td><td>101316</td><td>67</td><td>99</td><td>0.73 (0.69 – 0.77)</td></tr><tr>... |
a44d998e832ae56bb388847ec730cb1d2110cffb0ce84ab7f08ed64c0a2eb894.png | complex | <table><tr><td></td><td></td><td colspan="2">Model I</td><td colspan="2">Model II</td></tr><tr><td>Variable</td><td>Category</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr><tr><td><i>Fixed effects</i></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><i>Rate of change</i></td><td></td><td></td... | <table><tr><td></td><td></td><td colspan="2">Model I</td><td colspan="2">Model II</td></tr><tr><td>Variable</td><td>Category</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr><tr><td>Fixed effects</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Rate of change</td><td></td><td></td><td></td><td>... | <table><tr><td></td><td></td><td colspan="2">Model I</td><td colspan="2">Model II</td></tr><tr><td>Variable</td><td>Category</td><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr><tr><td rowspan="3">Smoking</td><td>Never</td><td></td><td></td><td>1</td><td></td></tr><tr><td>Former</td><td></td><td></td><td>1.01<... |
0d2295d6342b67526023ac936bb8dcb5e126aa2b535dcf2dbc9fead880d7e069.png | complex | <table><tr><td></td><td colspan="3">Assay 1(Quantitect, 2 min A&E)<underline>Primer Pairs</underline></td><td colspan="3">Assay 2(Quantifast, 1 min A&E)<underline>Primer Pairs</underline></td></tr><tr><td>Tree number (genotype)</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2<... | <table><tr><td></td><td colspan="3">Assay 1(Quantitect, 2 min A&E)Primer Pairs</td><td colspan="3">Assay 2(Quantifast, 1 min A&E)Primer Pairs</td></tr><tr><td>Tree number (genotype)</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2</td></tr><tr><td>Tree-14 (G-T/G-G)</td><td>1100</td><t... | <table><tr><td></td><td colspan="3">Assay 1(Quantitect, 2 min A&E)Primer Pairs</td><td colspan="3">Assay 2(Quantifast, 1 min A&E)Primer Pairs</td></tr><tr><td>Tree number (genotype)</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2</td><td>T1-C2</td><td>G1-A2</td><td>G1-C2</td></tr><tr><td>Tree -20 (G-T/G-G)</td><td>1500</td><... |
3a8dc09e8d3f319376c0c17fd84c289248811ff9ab06fadde32aa44a0d4fc2dc.png | complex | <table><tr><td>Exon</td><td>Mutation</td><td>Base change</td><td>Amino acid change</td><td>Mutated samples</td><td>%</td></tr><tr><td><i>BRAF</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td rowspan="2">15</td><td rowspan="2">V600E</td><td>1799</td><td rowspan="2">Val to Glu</td><td rowspan="2">34... | <table><tr><td>Exon</td><td>Mutation</td><td>Base change</td><td>Amino acid change</td><td>Mutated samples</td><td>%</td></tr><tr><td>BRAF</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="2">15</td><td rowspan="2">V600E</td><td>1799</td><td rowspan="2">Val to Glu</td><td rowspan="2">347</td><td ro... | <table><tr><td>Exon</td><td>Mutation</td><td>Base change</td><td>Amino acid change</td><td>Mutated samples</td><td>%</td></tr><tr><td>15</td><td>00D</td><td>> AT</td><td>p</td><td>6</td><td></td></tr><tr><td rowspan="2">15</td><td rowspan="2">V600R</td><td>1798-99</td><td rowspan="2">Val to Arg</td><td rowspan="2">2</t... |
8d3eb6e50e35f3e0edbe1796c200e4eaaef85b8f48618f69310871e2aa9d571a.png | simple | <table><tr><td></td><td>January</td><td>February</td><td>March</td><td>April</td><td>May</td><td>June</td><td>July</td><td>August</td><td>September</td><td>October</td><td>November</td><td>December</td></tr><tr><td> Number of sirocco days</td><td>0</td><td>0</td><td>0</td><td>3</td><td>26</td><td>59</td><td>111</td><td... | <table><tr><td></td><td>January</td><td>February</td><td>March</td><td>April</td><td>May</td><td>June</td><td>July</td><td>August</td><td>September</td><td>October</td><td>November</td><td>December</td></tr></table> | <table><tr><td>Number of sirocco days</td><td>0</td><td>0</td><td>0</td><td>3</td><td>26</td><td>59</td><td>111</td><td>53</td><td>11</td><td>0</td><td>0</td><td>0</td></tr></table> |
c703e8e40451f8725a29c3910b5f915a240f423474b1dee4fd6e304ade666aa0.png | complex | <table><tr><td rowspan="3">Biochemical parameters</td><td colspan="2">Control groups</td><td colspan="3">Treated groups</td></tr><tr><td>absolute</td><td>relative</td><td>Day 1</td><td>Day 7</td><td>Day 14</td></tr><tr><td>Glucose (mg dl-1)</td><td>125.0 ± 11.4</td><td>119.0 ± 19.5</td><td>122.0 ± 20.9</... | <table><tr><td rowspan="3">Biochemical parameters</td><td colspan="2">Control groups</td><td colspan="3">Treated groups</td></tr><tr><td>absolute</td><td>relative</td><td>Day 1</td><td>Day 7</td><td>Day 14</td></tr><tr><td colspan="5"></td></tr></table> | <table><tr><td>Glucose (mg dl-1)</td><td>125.0 ± 11.4</td><td>119.0 ± 19.5</td><td>122.0 ± 20.9</td><td>121.0 ± 18.0</td><td>118.0 ± 18.0</td></tr><tr><td>Urea (mg dl-1)</td><td>29.6 ± 3.5</td><td>30.8 ± 4.2</td><td>29.2 ± 1.8</td><td>30.7 ± 4.1</td><td>32.3 ± 3.6</td></tr><tr><td>Creatinine (mg dl-1)</td><td>0.33 ± 0.... |
54a05d11366549334c6f44ccfda4b3c10eba020d302b3fdcdecbcc9cfcb09756.png | simple | <table><tr><td>Movement of Households</td><td>Wealth index (PCA)</td><td>Consumption Expenditure</td></tr><tr><td>Proportion of households ranked in the same tercile</td><td>60.99</td><td>42.64</td></tr><tr><td>Proportion of households moving by one tercile</td><td>32.18</td><td>34.93</td></tr><tr><td>Proportion of hou... | <table><tr><td>Movement of Households</td><td>Wealth index (PCA)</td><td>Consumption Expenditure</td></tr><tr><td>Proportion of households ranked in the same tercile</td><td>60.99</td><td>42.64</td></tr><tr><td>Proportion of households moving by one tercile</td><td>32.18</td><td>34.93</td></tr><tr><td>Proportion of hou... | <table><tr><td>Kappa statistic</td><td>0.373***</td><td>0.122***</td></tr></table> |
75310de40e8d6d691a17136a5b81e84b9c38bee0c53bad40daf9d8b3b9c1666d.png | complex | <table><tr><td>InterPro entry</td><td>Signatures</td><td>Analysis method</td></tr><tr><td rowspan="4">IPR000043 (Family)</td><td>TIGR00936 (ahcY)</td><td>HMMTigr</td></tr><tr><td>PF05221 (AdoHcyase)</td><td>HMMPfam</td></tr><tr><td>PTHR23420 (Ad_hcy_hydrolase)</td><td>HMMPanther</td></tr><tr><td>PIRSF001109 (Ad_hcy_hyd... | <table><tr><td>InterPro entry</td><td>Signatures</td><td>Analysis method</td></tr><tr><td>IPR000043 (Family)</td><td>TIGR00936 (ahcY)</td><td>HMMTigr</td></tr></table> | <table><tr><td rowspan="3">IPR000043 (Family)</td><td>PF05221 (AdoHcyase)</td><td>HMMPfam</td></tr><tr><td>PTHR23420 (Ad_hcy_hydrolase)</td><td>HMMPanther</td></tr><tr><td>PIRSF001109 (Ad_hcy_hydrolase)</td><td>HMMPIR</td></tr><tr><td>IPR015878 (Domain)</td><td>PF00670 (AdoHcyase_NAD)</td><td>HMMPfam</td></tr><tr><td r... |
a223cd80bf53dd9841676e35b92db6c0537745ebb5d90359f6784ecf34bc4ad9.png | complex | <table><tr><td rowspan="2">Exposure</td><td colspan="3">Mean difference in gestational age acceleration (days)</td></tr><tr><td>Mean difference</td><td>95% CI</td><td><i>p</i></td></tr><tr><td>Female</td><td>− 0.8</td><td>− 1.4, − 0.1</td><td>0.024</td></tr><tr><td>High/non-manual parental social clas... | <table><tr><td rowspan="2">Exposure</td><td colspan="3">Mean difference in gestational age acceleration (days)</td></tr><tr><td>Mean difference</td><td>95% CI</td><td>p</td></tr><tr><td>Female</td><td>− 0.8</td><td>− 1.4, − 0.1</td><td>0.024</td></tr><tr><td>High/non-manual parental social class</td><td>0.1</td><td>− 0... | <table><tr><td rowspan="2">Exposure</td><td colspan="3">Mean difference in gestational age acceleration (days)</td></tr><tr><td>Mean difference</td><td>95% CI</td><td>p</td></tr><tr><td>ted (council/HA)</td><td>0.2</td><td>5</td><td></td></tr><tr><td colspan="4">Financial difficulties</td></tr><tr><td>None</td><td>(Ref... |
b9e816ea8f5bd15ebd370d6709b79b12eb3001ac1897e13fdf7ab4143d5c2970.png | simple | <table><tr><td>Component Label</td><td>Component</td><td>Subsystem function</td><td>Enjoyment of negative emotion example</td></tr><tr><td>1. Appraisal</td><td>Cognitive component</td><td>Evaluation of objects and events</td><td>Context detection/knowledge (music, aesthetic)</td></tr><tr><td>2. Bodily symptoms</td><td>... | <table><tr><td>Component Label</td><td>Component</td><td>Subsystem function</td><td>Enjoyment of negative emotion example</td></tr><tr><td>1. Appraisal</td><td>Cognitive component</td><td>Evaluation of objects and events</td><td>Context detection/knowledge (music, aesthetic)</td></tr></table> | <table><tr><td>Component Label</td><td>Component</td><td>Subsystem function</td><td>Enjoyment of negative emotion example</td></tr><tr><td>2. Bodily symptoms</td><td>Neurophysiological component</td><td>System regulation</td><td>Bodily symptoms of the negative emotion</td></tr><tr><td>3. Action tendencies</td><td>Motiv... |
4bc4890ff7374e5a078d1a45cde73181676e38f4b84beb658d7b9a54cc4320bb.png | complex | <table><tr><td colspan="2"> Domains</td><td> Average (± standard deviation)</td></tr><tr><td colspan="2"> HAT-QoL (n= 201)</td><td></td></tr><tr><td></td><td> Overall function</td><td> 79.39 (20.9)</td></tr><tr><td></td><td> Life satisfaction</td><td> 71.9 (24.4)</td></tr><tr><td></td><td> Health worries</td><td> ... | <table><tr><td colspan="2">Domains</td><td>Average (± standard deviation)</td></tr><tr><td colspan="2">HAT-QoL (n= 201)</td><td></td></tr><tr><td></td><td>Overall function</td><td>79.39 (20.9)</td></tr><tr><td></td><td>Life satisfaction</td><td>71.9 (24.4)</td></tr></table> | <table><tr><td colspan="2">Domains</td><td>Average (± standard deviation)</td></tr><tr><td></td><td>Health worries</td><td>83.2 (22.9)</td></tr><tr><td></td><td>Financial worries</td><td>55.6 (37.5)</td></tr><tr><td></td><td>Medication worries</td><td>88.7 (17.3)</td></tr><tr><td></td><td>HIV mastery</td><td>77.8 (33.6... |
2b710504152cf7b48804ddb17975da8f64b186fa53bee700eafed48c6b372e62.png | simple | <table><tr><td></td><td>Sha_w</td><td>Sha_15</td><td>BF_18</td><td>BF_22</td><td>ADGw_14</td><td>ADG14_22</td></tr><tr><td>Sha_w</td><td>0.04 ± 0.04</td><td>–</td><td>0.05 ± 0.03</td><td>0.06 ± 0.03</td><td>0.04 ± 0.03</td><td>0.07 ± 0.03</td></tr><tr><td>Sha_15</td><td>–</td><td>0.... | <table><tr><td></td><td>Sha_w</td><td>Sha_15</td><td>BF_18</td><td>BF_22</td><td>ADGw_14</td><td>ADG14_22</td></tr><tr><td>Sha_w</td><td>0.04 ± 0.04</td><td>–</td><td>0.05 ± 0.03</td><td>0.06 ± 0.03</td><td>0.04 ± 0.03</td><td>0.07 ± 0.03</td></tr><tr><td>Sha_15</td><td>–</td><td>0.18 ± 0.08</td><td>− 0.10 ± 0.03</td><... | <table><tr><td>ADGw_14</td><td>− 0.73 ± 0.51</td><td>− 0.53 ± 0.32</td><td>0.29 ± 0.32</td><td>–</td><td>0.09 ± 0.06</td><td>–</td></tr><tr><td>ADG14_22</td><td>0.44 ± 0.48</td><td>− 0.53 ± 0.29</td><td>0.10 ± 0.29</td><td>0.24 ± 0.28</td><td>–</td><td>0.17 ± 0.08</td></tr></table> |
ad38f0cb753294910ef67e27e48b1148671d5db428cfb856da062cad5a3b4650.png | simple | <table><tr><td>Gene</td><td>GenBank</td><td>Forward primer</td><td>Reverse primer</td><td>Amplicon</td></tr><tr><td>Name</td><td>Accession</td><td>5′ → 3′</td><td>5′ → 3′</td><td>Size (bp)</td></tr><tr><td>CD25</td><td>NM_174358</td><td>AGATGTCCTGGCTTGAAC</td><td>TGGATATAGACCTGCTAATA... | <table><tr><td>Gene</td><td>GenBank</td><td>Forward primer</td><td>Reverse primer</td><td>Amplicon</td></tr><tr><td>Name</td><td>Accession</td><td>5′ → 3′</td><td>5′ → 3′</td><td>Size (bp)</td></tr><tr><td>CD25</td><td>NM_174358</td><td>AGATGTCCTGGCTTGAAC</td><td>TGGATATAGACCTGCTAATACC</td><td>134</td></tr><tr><td>CCNA... | <table><tr><td>CCNB1</td><td>XM_005694606</td><td>TTGATGGAACTGACTATGCTGGACT</td><td>CAGGTAATGCTGTAGAGTTGGTGTC</td><td>132</td></tr><tr><td>CCND1</td><td>XM_005700049</td><td>AGGAGGTGAGGGTGGAAGTGTG</td><td>GAAGTCATCGGTAGCAGCGAATAA</td><td>100</td></tr><tr><td>GAPDH</td><td>DQ152956</td><td>CCTGGAGAAACCTGCCAAGT</td><td>G... |
a61ed153af04aa56ee50a96ea6437a1e598b9a0feae6bbf2dfc2096a7e2ccf6a.png | simple | <table><tr><td>Software</td><td>Normal</td><td>Truncated</td><td>Solo-LTR</td><td>Complex</td><td>Nested</td><td>Total</td></tr><tr><td>LTRtype</td><td>59</td><td>200</td><td>172</td><td>7</td><td>182</td><td>438</td></tr><tr><td>REannotate</td><td>64</td><td>401</td><td>115</td><td>0</td><td>230</td><td>580</td></tr><... | <table><tr><td>Software</td><td>Normal</td><td>Truncated</td><td>Solo-LTR</td><td>Complex</td><td>Nested</td><td>Total</td></tr><tr><td>LTRtype</td><td></td><td>20</td><td>1</td><td></td><td>18</td><td>4</td></tr></table> | <table><tr><td></td><td>59</td><td>0</td><td>72</td><td>7</td><td>2</td><td>38</td></tr><tr><td>REannotate</td><td>64</td><td>401</td><td>115</td><td>0</td><td>230</td><td>580</td></tr><tr><td>TEnest</td><td>49</td><td>281</td><td>119</td><td>0</td><td>427</td><td>449</td></tr></table> |
199ea90fe4a77ba724b33d42575768ace715f7e0ada719c8873a404cfc15cabb.png | simple | <table><tr><td>Diagnostic Group</td><td>Number (men/women)</td><td>Age at Symptom Onset*</td><td>Age at PET Scan*</td><td>MMSE Score (max = 30)<sup>+</sup></td><td>Disease Duration (years)*</td></tr><tr><td>Cohort</td><td>102 (55/47)</td><td>60.06 (4.28)</td><td>64.04 (8.90)</td><td>25 (5–30)</td><td>5.74 (2.75)<... | <table><tr><td>Diagnostic Group</td><td>Number (men/women)</td><td>Age at Symptom Onset*</td><td>Age at PET Scan*</td><td>MMSE Score (max = 30)+</td><td>Disease Duration (years)*</td></tr><tr><td>Cohort</td><td>102 (55/47)</td><td>60.06 (4.28)</td><td>64.04 (8.90)</td><td>25 (5–30)</td><td>5.74 (2.75)</td></tr><tr><td>... | <table><tr><td>Diagnostic Group</td><td>Number (men/women)</td><td>Age at Symptom Onset*</td><td>Age at PET Scan*</td><td>MMSE Score (max = 30)+</td><td>Disease Duration (years)*</td></tr><tr><td>PA</td><td> (3/3)</td><td>18 (8.66)</td><td>67.54 (7.59)</td><td>1.00 (10.65)</td><td>.28 (3.37)</td></tr><tr><td>Depress</t... |
f588294c245ec0e388f74809e78d512731a8aa3f72ad6b6ba33ae42abaddc7b3.png | complex | <table><tr><td>Serotype</td><td>All</td><td colspan="2">Fatal outcome</td><td colspan="2">Any risk factor</td><td colspan="2">Pneumonia</td><td colspan="2">Meningitis</td></tr><tr><td> </td><td>No</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value... | <table><tr><td>Serotype</td><td>All</td><td colspan="2">Fatal outcome</td><td colspan="2">Any risk factor</td><td colspan="2">Pneumonia</td><td colspan="2">Meningitis</td></tr><tr><td></td><td>No</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value</td><td>No (%)</td><td>P-value<... | <table><tr><td>Serotype</td><td>Fatal outcome</td><td>Any risk factor</td><td>Pneumonia</td><td>Meningitis</td></tr><tr><td></td><td>No (%)</td><td>No (%)</td><td>No (%)</td><td>No (%)</td></tr><tr><td>All serotypes</td><td>37 (26.8%)</td><td>107 (77.5%)</td><td>64 (47.1%)</td><td>36 (26.5%)</td></tr></table> |
2cf86b43f16cd78c038b7033bc52a5961510c3ff67a37fad5a8a524e27f571a2.png | simple | <table><tr><td>Age</td><td><i>n</i></td><td>Total number ofCPECs counted</td><td>PP+ve CPECs</td><td>BrdU+ve CPECs</td><td>PP/BrdUdouble-labelled CPECs(<i>n </i>= 4)</td></tr><tr><td>P3</td><td>6</td><td>1855 ± 260</td><td>131 ± 36</td><td>44 ± 3</td><td>0</td></tr><tr><td>P4</td><td>6</td><td>2060 ±... | <table><tr><td>Age</td><td>n</td></tr><tr><td>P3</td><td>6</td></tr><tr><td>P4</td><td>6</td></tr><tr><td>P5</td><td>6</td></tr><tr><td>P10</td><td>6</td></tr><tr><td>P30</td><td>6</td></tr><tr><td>P45</td><td>6</td></tr><tr><td>P65</td><td>6</td></tr><tr><td>p value *</td><td></td></tr></table> | <table><tr><td>Total number ofCPECs counted</td><td>PP+ve CPECs</td><td>BrdU+ve CPECs</td><td>PP/BrdUdouble-labelled CPECs(n = 4)</td></tr><tr><td>1855 ± 260</td><td>131 ± 36</td><td>44 ± 3</td><td>0</td></tr><tr><td>2060 ± 125</td><td>175 ± 12</td><td>59 ± 7</td><td>2 ± 1</td></tr><tr><td>2675 ± 205</td><td>216 ± 33</... |
459fa140895f04397c6042a5e405767b4dd3478fa03c6a2ed06c2b0d11e8d61a.png | simple | <table><tr><td>Operational challenge</td><td>Description</td></tr><tr><td>High workload</td><td>- One of the major concerns was that the increased utilisation has put so much pressure on the limited medical staff in the facilities. There is large health worker-patient ratio and this affects the provision of responsive ... | <table><tr><td>Operational challenge</td><td>Description</td></tr><tr><td>High workload</td><td>- One of the major concerns was that the increased utilisation has put so much pressure on the limited medical staff in the facilities. There is large health worker-patient ratio and this affects the provision of responsive ... | <table><tr><td>Description</td></tr><tr><td>- Because the system is not properly networked, there were instances when unregistered members scan their passport size pictures on ID cards of active members in order to receive medical care.</td></tr></table> |
8b1e1ddfa550ecde33b09f99eb9d2258ce39dfd576eb3d9a6c0ac14e702d9946.png | complex | <table><tr><td rowspan="3">Wound dressing material</td><td colspan="2">Mean value ± standard error of the mean</td></tr><tr><td colspan="2">(number of vessels per high-power field)</td></tr><tr><td>The 7th postoperative day</td><td>The 10th postoperative day</td></tr><tr><td>Human amniotic membrane</td><td>0.90 &#... | <table><tr><td rowspan="3">Wound dressing material</td><td>Mean value ± standard error of the mean</td></tr><tr><td>(number of vessels per high-power field)</td></tr><tr><td>The 7th postoperative day</td></tr><tr><td>Human amniotic membrane</td><td>0.90 ± 0.18</td></tr><tr><td>Polyurethane foil</td><td>1.80 ± 0.16</td>... | <table><tr><td>Mean value ± standard error of the mean</td></tr><tr><td>(number of vessels per high-power field)</td></tr><tr><td>The 10th postoperative day</td></tr><tr><td>1.05 ± 0.14</td></tr><tr><td>4.70 ± 0.47</td></tr></table> |
b7c760b1cb916d81cdc5dc4c623eccf15bd0657e0920015d13e78c257d2e535a.png | simple | <table><tr><td>Group</td><td>Articles, n</td><td>Studies, n</td><td>Sensitivity (95% ci),%</td><td>Specificity (95% ci),%</td></tr><tr><td>All data</td><td>103</td><td>132</td><td>70.8 (68.3-73.2)</td><td>95.8 (94.9-96.6)</td></tr><tr><td>Effect of STARD score</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Hi... | <table><tr><td>Group</td><td>Articles, n</td><td>Studies, n</td><td>Sensitivity (95% ci),%</td><td>Specificity (95% ci),%</td></tr><tr><td>All data</td><td>103</td><td>132</td><td>70.8 (68.3-73.2)</td><td>95.8 (94.9-96.6)</td></tr><tr><td>Effect of STARD score</td><td></td><td></td><td></td><td></td></tr><tr><td>High q... | <table><tr><td>Effect of STARD item 16</td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>55</td><td>66</td><td>73.3 (69.8-76.6)</td><td>94.6 (93.2-95.8)*</td></tr><tr><td>No</td><td>48</td><td>66</td><td>68.3 (64.9-71.5)</td><td>96.8 (95.7-97.7)</td></tr><tr><td>Effect of STARD item 19</td><td></td><td><... |
f1fee9145939dd993fd143836e13e41056e72a8dbe6f9f5c7d12caf00fbc4627.png | simple | <table><tr><td>Property</td><td>Description</td><td>Encoding</td></tr><tr><td>TF_Class</td><td>Encoded 2–3 top levels of five digit code based on TFClass classification; i.e. superclass followed by class (see text)</td><td>A 47-dimensional vector where i<sup>th</sup> position (superclass) and j<sup>th</sup> posit... | <table><tr><td>Property</td><td>Description</td><td>Encoding</td></tr><tr><td>TF_Class</td><td>Encoded 2–3 top levels of five digit code based on TFClass classification; i.e. superclass followed by class (see text)</td><td>A 47-dimensional vector where ith position (superclass) and jth position (class) are 1, other pos... | <table><tr><td>N_ZFD</td><td>Number of the zinc finger domains (see text)</td><td>11/10/00</td></tr></table> |
83195f572ca1f684b720505d30cd0220eae525e2011f06747d834e9041dd89ac.png | simple | <table><tr><td>Gender</td><td> </td><td><i>n </i>(%)</td></tr><tr><td> </td><td>Female</td><td>20 (43.5)</td></tr><tr><td> </td><td>Male</td><td>26 (56.5)</td></tr><tr><td>Age</td><td> </td><td>Years (range)</td></tr><tr><td> </td><td>Mean</td><td>32 (18–37)</td></tr><tr><td>HSCT</td><td> </td><td><i>n </i>(%)</t... | <table><tr><td>Gender</td><td></td><td>n (%)</td></tr><tr><td></td><td>Female</td><td>20 (43.5)</td></tr><tr><td></td><td>Male</td><td>26 (56.5)</td></tr><tr><td>Age</td><td></td><td>Years (range)</td></tr><tr><td></td><td>Mean</td><td>32 (18–37)</td></tr><tr><td>HSCT</td><td></td><td>n (%)</td></tr><tr><td></td><td>Al... | <table><tr><td></td><td>Multiple myeloma</td><td>6 (13.1)</td></tr><tr><td></td><td>Hodgkin’s lymphoma</td><td>3 (6.5)</td></tr><tr><td></td><td>Severe aplastic anemia</td><td>3 (6.5)</td></tr><tr><td>Immunosuppressive conditioning regimen</td><td></td><td>n (%)</td></tr><tr><td></td><td>Busulfan and melphalan</td><td>... |
a78c682b0d640055a0452c3a5b0038e102fe153104534f60cf321834c74b6b2a.png | complex | <table><tr><td></td><td colspan="4">Modality</td><td colspan="4">Figurativeness</td></tr><tr><td></td><td colspan="2">Motion metaphor/Auditory metaphor</td><td colspan="2">Motion literal/Auditory literal</td><td colspan="2">Motion literal/Motion metaphor</td><td colspan="2">Auditory literal/Auditory metaphor</td></tr><... | <table><tr><td></td><td colspan="4">Modality</td><td colspan="4">Figurativeness</td></tr><tr><td></td><td colspan="2">Motion metaphor/Auditory metaphor</td><td colspan="2">Motion literal/Auditory literal</td><td colspan="2">Motion literal/Motion metaphor</td><td colspan="2">Auditory literal/Auditory metaphor</td></tr><... | <table><tr><td></td><td colspan="4">Modality</td><td colspan="4">Figurativeness</td></tr><tr><td></td><td colspan="2">Motion metaphor/Auditory metaphor</td><td colspan="2">Motion literal/Auditory literal</td><td colspan="2">Motion literal/Motion metaphor</td><td colspan="2">Auditory literal/Auditory metaphor</td></tr><... |
016f6c7431897d4879bf4a6f7a2626a2f13827de93bb15de8849b0f4d001d0bf.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Drainage</td><td colspan="2">No drain</td><td></td></tr><tr><td>Median (25<sup>th</sup> – 75<sup>th</sup> percentile)</td><td>Mean (± SD)</td><td>Median (25<sup>th</sup> – 75<sup>th</sup> percentile)</td><td>Mean (± SD)</td><td><i>p</i>-value</td></t... | <table><tr><td rowspan="2"></td><td colspan="2">Drainage</td><td colspan="2">No drain</td><td></td></tr><tr><td>Median (25th – 75th percentile)</td><td>Mean (± SD)</td><td>Median (25th – 75th percentile)</td><td>Mean (± SD)</td><td>p-value</td></tr><tr><td>Volume drained (ml)</td><td>500.00 (233.50 – 864.00)</td><td>58... | <table><tr><td>Total drained (ml)</td><td>720.00 (395.00 – 1145.00)</td><td>779.30 (451.90)</td><td>540.00 (215.00 – 1152.50)</td><td>890.60 (1434.30)</td><td>0.19</td></tr></table> |
4dd31d0c7958e24d96878af0efdad9a927e426925a5d849545bac78f01489a79.png | simple | <table><tr><td></td><td>Cluster I</td><td>Cluster II</td><td>Cluster III</td></tr><tr><td>Cluster I</td><td>0</td><td>1.76</td><td>1.72</td></tr><tr><td>Cluster II</td><td>0.14230</td><td>0</td><td>2.80</td></tr><tr><td>Cluster III</td><td>0.14540</td><td>0.08917</td><td>0</td></tr></table> | <table><tr><td></td><td>Cluster I</td><td>Cluster II</td><td>Cluster III</td></tr><tr><td>Cluster I</td><td>0</td><td>1.76</td><td>1.72</td></tr></table> | <table><tr><td>Cluster II</td><td>0.14230</td><td>0</td><td>2.80</td></tr><tr><td>Cluster III</td><td>0.14540</td><td>0.08917</td><td>0</td></tr></table> |
18a394ba3e33e9be12c452dfec12e8797313101beba6f070f6378723ff562eb2.png | simple | <table><tr><td>Sample sources</td><td>TYLCV positive No./tomato sample No.</td><td>TYLCV positive No./whiltefly No.</td></tr><tr><td>Henan Province</td><td>6,6,6/9<sup>a</sup></td><td>7,7 /22 <sup>b</sup></td></tr><tr><td>Shandong Province</td><td>30,30,30/56</td><td>11,11/20</td></tr><tr><td>Zhejiang Province</td><td>... | <table><tr><td>Sample sources</td></tr><tr><td>Henan Province</td></tr><tr><td>Shandong Province</td></tr><tr><td>Zhejiang Province</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>TYLCV positive No./tomato sample No.</td><td>TYLCV positive No./whiltefly No.</td></tr><tr><td>6,6,6/9a</td><td>7,7 /22 b</td></tr><tr><td>30,30,30/56</td><td>11,11/20</td></tr><tr><td>195,195,197 /422</td><td>21,21/68</td></tr><tr><td>231, 231,233 /487</td><td>39,39/110</td></tr></table> |
0e304302c32b80043975c0db421131b20ec83ab0d5d1b83207b350efbdd5375b.png | complex | <table><tr><td>GBB-24 scale and sub-scales</td><td colspan="4">m / M<sub>e</sub>(95%CI)</td><td><i>P</i>-values<sup>a</sup></td></tr><tr><td> </td><td colspan="2">Financial problems</td><td colspan="2">The problems disappeared</td><td> </td></tr><tr><td> </td><td>Yes</td><td>No</td><td>Yes</td><td>No</td><td> </td></tr... | <table><tr><td>GBB-24 scale and sub-scales</td><td colspan="4">m / Me(95%CI)</td><td>P-valuesa</td></tr><tr><td></td><td colspan="2">Financial problems</td><td colspan="2">The problems disappeared</td><td></td></tr><tr><td></td><td>Yes</td><td>No</td><td>Yes</td><td>No</td><td></td></tr></table> | <table><tr><td></td><td>(n=98)</td><td>(n=106)</td><td>(n=83)</td><td>(n=121)</td><td></td></tr><tr><td rowspan="2">Exhaustion</td><td>8.16 / 8</td><td>6.98 / 7</td><td>6.96 / 7</td><td>7.95 / 7</td><td>1 P=0.108</td></tr><tr><td>(7.18–9.15)</td><td>(6.14–7.82)</td><td>(6.04–7.89)</td><td>(7.06–8.84)</td><td>2 P=0.225<... |
3a4d4c3b879eea9da59b979547d758ba749a7267f6f45ca0b74042b79967551a.png | complex | <table><tr><td> No. of teeth</td><td colspan="3"> Oral impacts</td><td rowspan="2"> Sn</td><td rowspan="2">Sp</td><td rowspan="2"> PPV</td><td rowspan="2">NPV</td></tr><tr><td>Cutoff</td><td>With</td><td>Without</td><td>Total</td></tr><tr><td>≤24</td><td> 73</td><td> 93</td><td> 166</td><td rowspan="3">0.69</td><... | <table><tr><td>No. of teeth</td><td>Oral impacts</td></tr><tr><td>Cutoff</td><td>With</td></tr><tr><td>≤24</td><td>73</td></tr><tr><td>≥25</td><td>31</td></tr><tr><td>Total</td><td>104</td></tr></table> | <table><tr><td colspan="2">Oral impacts</td><td rowspan="2">Sn</td><td rowspan="2">Sp</td><td rowspan="2">PPV</td><td rowspan="2">NPV</td></tr><tr><td>Without</td><td>Total</td></tr><tr><td>93</td><td>166</td><td rowspan="3">0.69</td><td rowspan="3">0.70</td><td rowspan="3">0.87</td><td rowspan="3">0.44</td></tr><tr><t... |
15ed58ccd5e78234143919e8aba14208c931f3843019ad14abe867b1d652a521.png | complex | <table><tr><td>Outcome</td><td>Aligner</td><td>Bracket</td><td><i>P</i>*</td></tr><tr><td></td><td>Mean (SD)</td><td>Mean (SD)</td><td></td></tr><tr><td colspan="4">s-PlI T0 (transformed)</td></tr><tr><td> T0</td><td>5.34 (0.87)</td><td>5.55 (1.08)</td><td>0.56</td></tr><tr><td> T1</td><td>3.97 (1.29)</td><td>5.72 (1.2... | <table><tr><td>Outcome</td></tr><tr><td></td></tr><tr><td>s-PlI T0 (transformed)</td></tr><tr><td>T0</td></tr><tr><td>T1</td></tr><tr><td>T2</td></tr><tr><td>s-GI T0 (transformed)</td></tr><tr><td>T0</td></tr><tr><td>T1</td></tr><tr><td>T2</td></tr></table> | <table><tr><td>Aligner</td><td>Bracket</td><td>P*</td></tr><tr><td>Mean (SD)</td><td>Mean (SD)</td><td></td></tr><tr><td colspan="3">s-PlI T0 (transformed)</td></tr><tr><td>5.34 (0.87)</td><td>5.55 (1.08)</td><td>0.56</td></tr><tr><td>3.97 (1.29)</td><td>5.72 (1.24)</td><td>0.001</td></tr><tr><td>4.80 (1.48)</td><td>6.... |
4e2cf266eb2f8a1cf8dc7ed6d492253ffedba10c77b4939530932aeea3fa4486.png | complex | <table><tr><td rowspan="2">Treatment</td><td colspan="2">Superfused bath</td><td colspan="2">Static bath</td><td rowspan="2">Significance (Student’s t test)</td></tr><tr><td>n</td><td>Released ATP*</td><td>n</td><td>Released ATP*</td></tr><tr><td>Control (Ringer’s)</td><td>89 puncta, 3 slices</td><td>65 ... | <table><tr><td rowspan="2">Treatment</td><td colspan="2">Superfused bath</td><td colspan="2">Static bath</td><td rowspan="2">Significance (Student’s t test)</td></tr><tr><td>n</td><td>Released ATP*</td><td>n</td><td>Released ATP*</td></tr></table> | <table><tr><td>Control (Ringer’s)</td><td>89 puncta, 3 slices</td><td>65 ± 1%</td><td>80 puncta, 3 slices</td><td>66 ± 2%</td><td>p = 0.61</td></tr><tr><td>PPADS</td><td>75 puncta, 2 slices</td><td>62 ± 3%</td><td>82 puncta, 2 slices</td><td>64 ± 1%</td><td>p = 0.41</td></tr><tr><td>αβMeATP</td><td>144 puncta, 4 slices... |
fbb819dd07294a9d3a10835b7192172f70a9e2fc30c64a53044979b5e66f30af.png | simple | <table><tr><td>Media Volume (mL)</td><td>Biomass (mg)</td><td>RGR <sup>1</sup>(mg·mg<sup>−1</sup>·d<sup>−1</sup>)</td><td>Dry Weight per mL(mg·mL<sup>−1</sup>)</td><td>CA Content <sup>2</sup>(μg·gDW<sup>−1</sup>)</td><td>CA Production <sup>3</sup>(μg·mL<sup>... | <table><tr><td>Media Volume (mL)</td><td>Biomass (mg)</td><td>RGR 1(mg·mg−1·d−1)</td><td>Dry Weight per mL(mg·mL−1)</td><td>CA Content 2(μg·gDW−1)</td><td>CA Production 3(μg·mL−1)</td></tr><tr><td>15</td><td>23</td><td>0.378 ± 0.002</td><td>1.580 ± 0.05 a</td><td>898.2</td><td>1.421 ± 0.228 a</td></tr></table> | <table><tr><td></td><td>.60 ± 0.60 c</td><td> c</td><td></td><td> ± 101 a</td><td></td></tr><tr><td>30</td><td>38.00 ± 1.14 b</td><td>0.395 ± 0.002 b</td><td>1.260 ± 0.04 b</td><td>576.8 ± 96 b</td><td>0.735 ± 0.174 b</td></tr><tr><td>60</td><td>61.60 ± 1.81 a</td><td>0.412 ± 0.002 a</td><td>1.040 ± 0.02 c</td><td>335.... |
b85f19655186c820d7bd14a5df8bbc7c904c457d97a123e4d3639e8e7df13192.png | complex | <table><tr><td>Cluster size</td><td>Hemisphere</td><td>Brain region</td><td>BA</td><td>MNI coordinates</td><td>Peak <i>T</i>-value</td></tr><tr><td colspan="6">POSITIVE RSFCs: PRE > POST</td></tr><tr><td>117</td><td>Right</td><td>Insula/inferior frontal gyrus</td><td>13/45/44</td><td>63, 18, 3</td><td>6.60</td></tr>... | <table><tr><td>Cluster size</td><td>Hemisphere</td><td>Brain region</td><td>BA</td><td>MNI coordinates</td><td>Peak T-value</td></tr><tr><td colspan="6">POSITIVE RSFCs: PRE > POST</td></tr></table> | <table><tr><td>117</td><td>Right</td><td>Insula/inferior frontal gyrus</td><td>13/45/44</td><td>63, 18, 3</td><td>6.60</td></tr><tr><td>74</td><td>Right</td><td>Middle frontal gyrus/superior frontal gyrus</td><td>6</td><td>33, −3, 66</td><td>5.14</td></tr><tr><td>64</td><td>Left</td><td>Insula</td><td>13</td><td>−39, 6... |
be85111812350d67fcd61b228ebc3839ad5da1cc1a9d1be24b9f83f5f8f4168d.png | complex | <table><tr><td>Aim</td><td colspan="10">Average-measure reliability <i>G(q,</i>k<i>)</i></td></tr><tr><td>Domain</td><td>Searching for research</td><td>Research obtained</td><td>Relevance appraisal</td><td>Quality appraisal</td><td>Generating new research</td><td>Interacting with researchers</td><td>Conceptual research... | <table><tr><td>Aim</td><td colspan="10">Average-measure reliability G(q,k)</td></tr><tr><td>Domain</td><td>Searching for research</td><td>Research obtained</td><td>Relevance appraisal</td><td>Quality appraisal</td><td>Generating new research</td><td>Interacting with researchers</td><td>Conceptual research use</td><td>I... | <table><tr><td>Aim</td><td colspan="10">Average-measure reliability G(q,k)</td></tr><tr><td>Domain</td><td>Searching for research</td><td>Research obtained</td><td>Relevance appraisal</td><td>Quality appraisal</td><td>Generating new research</td><td>Interacting with researchers</td><td>Conceptual research use</td><td>I... |
087840edc65c17ca5573d5bc2c7ee0d267ed2192799111e4bfe85db2e8239434.png | simple | <table><tr><td></td><td>Corrected item-total correlation</td><td>Cronbach’s α if an item deleted</td></tr><tr><td>Item 1</td><td>0.734</td><td>0.876</td></tr><tr><td>Item 2</td><td>0.667</td><td>0.881</td></tr><tr><td>Item 3</td><td>0.563</td><td>0.892</td></tr><tr><td>Item 4</td><td>0.727</td><td>0.876</td>... | <table><tr><td></td><td>Corrected item-total correlation</td><td>Cronbach’s α if an item deleted</td></tr><tr><td>Item 1</td><td>0.734</td><td>0.876</td></tr><tr><td>Item 2</td><td>0.667</td><td>0.881</td></tr><tr><td>Item 3</td><td>0.563</td><td>0.892</td></tr><tr><td>Item 4</td><td>0.727</td><td>0.876</td></tr><tr><t... | <table><tr><td>Item 9</td><td>0.641</td><td>0.885</td></tr></table> |
7b7c2933a0752cdebf5f564ff2b85dd602c9d262d43e6fc481a574fe4823b355.png | simple | <table><tr><td>Items</td><td>Days to flowering</td><td>Days to maturity</td><td>Plant height</td><td>Branch per plant</td><td>Pods per plant</td><td>Seeds per pod</td><td>100-seed wt (gm)</td><td>Yield perplant</td></tr><tr><td> Days to flowering</td><td>−0.646</td><td>1.102</td><td>−0.170</td><td>−0.... | <table><tr><td>Items</td><td>Days to flowering</td><td>Days to maturity</td><td>Plant height</td><td>Branch per plant</td><td>Pods per plant</td><td>Seeds per pod</td><td>100-seed wt (gm)</td><td>Yield perplant</td></tr></table> | <table><tr><td>Days to flowering</td><td>−0.646</td><td>1.102</td><td>−0.170</td><td>−0.141</td><td>0.253</td><td>0.405</td><td>−0.157</td><td>0.646∗∗</td></tr><tr><td>Days to maturity</td><td>−0.601</td><td>1.184</td><td>−0.161</td><td>−0.111</td><td>0.188</td><td>0.173</td><td>−0.005</td><td>0.667∗∗</td></tr><tr><td>... |
aca8f9da0ba8904acc43b441e51f5954788b11ccad0aec7b9ab93072ff972cea.png | complex | <table><tr><td colspan="2"> </td><td> </td><td>Male</td><td>Female</td></tr><tr><td colspan="2"> </td><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Total</td><td> </td><td>3450 (100)</td><td>1413 (42.0)</td><td>2037 (58.0)</td></tr><tr><td rowspan="5">Age (n=3450)</td><td>15-24</td><td>1100 (28)</td><td>506 (2... | <table><tr><td colspan="2"></td><td></td><td>Male</td><td>Female</td></tr><tr><td colspan="2"></td><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Total</td><td></td><td>3450 (100)</td><td>1413 (42.0)</td><td>2037 (58.0)</td></tr><tr><td rowspan="5">Age (n=3450)</td><td>15-24</td><td>1100 (28)</td><td>506 (27.9)... | <table><tr><td colspan="2"></td><td></td><td>Male</td><td>Female</td></tr><tr><td colspan="2"></td><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td>Employment (n=3425)</td><td>Retired/Home</td><td>697 (20.2)</td><td>167 (11.8)</td><td>530 (25.9)</td></tr></table> |
256805d16c45c913c062081fb0efee0254f132190f255a1453d9bfa4cb414d38.png | simple | <table><tr><td>Question – Recommender’s method</td><td>Automation</td><td>Fast enough</td><td>Accuracy</td></tr><tr><td>Which ontologies offer the maximum coverage for my data? – (CR – score)</td><td>Yes</td><td>Yes</td><td>Yes</td></tr><tr><td>Which ontologies are reference ontologies for my da... | <table><tr><td>Question – Recommender’s method</td><td>Automation</td><td>Fast enough</td><td>Accuracy</td></tr><tr><td>Which ontologies offer the maximum coverage for my data? – (CR – score)</td><td>Yes</td><td>Yes</td><td>Yes</td></tr></table> | <table><tr><td>Which ontologies are reference ontologies for my data? – (CR+M – score)</td><td>Yes</td><td>No</td><td>Yes</td></tr><tr><td>Which small ontologies are specialized for my data? – (CR – normalized score)</td><td>Yes</td><td>Yes</td><td>Not enough</td></tr></table> |
dff2d3557ac91999c78b16279c11718f41f332875c3647c495e038a83fc1854c.png | simple | <table><tr><td>Complication</td><td>Number of patients (<i>n</i>)</td><td>Treatment</td></tr><tr><td>Reflux +/− heartburn</td><td>21</td><td>Medical +/− endoscopy +/− pH 24 h esophageal pH monitoring </td></tr><tr><td>Vomiting</td><td>5</td><td>Diet modifications</td></tr><tr><td>Hemorrhage </td><td>7... | <table><tr><td>Complication</td><td>Number of patients (n)</td><td>Treatment</td></tr><tr><td>Reflux +/− heartburn</td><td>21</td><td>Medical +/− endoscopy +/− pH 24 h esophageal pH monitoring</td></tr><tr><td>Vomiting</td><td>5</td><td>Diet modifications</td></tr><tr><td>Hemorrhage</td><td>7</td><td>4 surgical, 3 tran... | <table><tr><td>r vein</td><td>1</td><td></td></tr><tr><td>Total</td><td>51</td><td></td></tr></table> |
2b3454d83977be4ab5e018f54dab50dab22b0d803fbff18766cf892bafc56f24.png | simple | <table><tr><td>Maternal</td><td>Neonatal</td><td>Process/intervention</td></tr><tr><td>Gestational weight gain</td><td>Body composition, anthropometry</td><td>Visit attendance</td></tr><tr><td>Preeclampsia*</td><td>Preterm delivery</td><td>Adherence to probiotic/placebo regimen</td></tr><tr><td>Induction of labor</td><... | <table><tr><td>Maternal</td><td>Neonatal</td><td>Process/intervention</td></tr><tr><td>Gestational weight gain</td><td>Body composition, anthropometry</td><td>Visit attendance</td></tr><tr><td>Preeclampsia*</td><td>Preterm delivery</td><td>Adherence to probiotic/placebo regimen</td></tr><tr><td>Induction of labor</td><... | <table><tr><td>Elective</td><td>Treatment with supplementary fluids/feeds</td></tr><tr><td>Emergency</td><td></td></tr><tr><td>Change in prevalence of L. rhamnosus and B. lactis in gut microbiome</td><td>Nerve palsy</td></tr><tr><td>Change in lipids and inflammatory profile</td><td>Admission to neonatal intensive care ... |
d48e87923585a4a59500ce962ac71c4de8173650e266ed8db7ef1a9c63f73f2d.png | simple | <table><tr><td>Sample</td><td>Total Polyphenol Contents (μg Gallic Acid/mL)</td></tr><tr><td><i>LJ</i></td><td>2.084 ± 0.01 <sup>(1)</sup></td></tr><tr><td><i>HF</i></td><td>3.215 ± 0.08</td></tr></table> | <table><tr><td>Sample</td></tr><tr><td>LJ</td></tr><tr><td>HF</td></tr></table> | <table><tr><td>Total Polyphenol Contents (μg Gallic Acid/mL)</td></tr><tr><td>2.084 ± 0.01 (1)</td></tr><tr><td>3.215 ± 0.08</td></tr></table> |
51de042de96383f957120023cea101ade7a922eea5e4774d187f6e92209c1714.png | simple | <table><tr><td></td><td>CAPEA</td><td>RABBIT</td><td>NDB</td><td>Reference (DEAS)</td></tr><tr><td><i>N</i></td><td>1033</td><td>12,230</td><td>3424</td><td>6202</td></tr><tr><td>Age (years), mean (SD)</td><td>56.6 (14.2)</td><td>56.2 (9.7)</td><td>61.5 (13.7)</td><td>61.5 (12.1)</td></tr><tr><td>Sex (female), n (%)</t... | <table><tr><td></td><td>CAPEA</td><td>RABBIT</td><td>NDB</td><td>Reference (DEAS)</td></tr><tr><td>N</td><td>1033</td><td>12,230</td><td>3424</td><td>6202</td></tr><tr><td>Age (years), mean (SD)</td><td>56.6 (14.2)</td><td>56.2 (9.7)</td><td>61.5 (13.7)</td><td>61.5 (12.1)</td></tr><tr><td>Sex (female), n (%)</td><td>6... | <table><tr><td>(SD)</td><td> (1.3)</td><td>2 (1.3)</td><td> (1.2)</td><td></td></tr><tr><td>BMI (kg/m2), mean (SD)</td><td>27.0 (5.0)</td><td>26.7 (5.3)</td><td>26.5 (4.9)</td><td>26.6 (4.2)</td></tr><tr><td>< 18.5, n (%)</td><td>11 (1.1)</td><td>263 (2.2)</td><td>56 (1.6)</td><td>45 (0.8)</td></tr><tr><td>18.5 to <25,... |
5ade0008b55c7f6ee483caa1bd9d2dd6cc62f7366fe96406eb064c2917137f76.png | complex | <table><tr><td rowspan="2">Histology parameters</td><td colspan="3">IBA-1</td><td colspan="3">GFAP</td><td colspan="3">MBP</td><td colspan="3">APP</td></tr><tr><td><i>t</i>(8)</td><td><i>p</i></td><td>Adj <i>p</i></td><td><i>t</i>(8)</td><td><i>p</i></td><td>Adj <i>p</i></td><td><i>t</i>(8)</td><td><i>p</i></td><td>Adj... | <table><tr><td rowspan="2">Histology parameters</td><td colspan="3">IBA-1</td><td colspan="3">GFAP</td><td colspan="3">MBP</td><td colspan="3">APP</td></tr><tr><td>t(8)</td><td>p</td><td>Adj p</td><td>t(8)</td><td>p</td><td>Adj p</td><td>t(8)</td><td>p</td><td>Adj p</td><td>t(8)</td><td>p</td><td>Adj p</td></tr><tr><td... | <table><tr><td rowspan="2">Histology parameters</td><td colspan="3">IBA-1</td><td colspan="3">GFAP</td><td colspan="3">MBP</td><td colspan="3">APP</td></tr><tr><td>t(8)</td><td>p</td><td>Adj p</td><td>t(8)</td><td>p</td><td>Adj p</td><td>t(8)</td><td>p</td><td>Adj p</td><td>t(8)</td><td>p</td><td>Adj p</td></tr><tr><td... |
3687848e6850f525014c11cf9c80f3ff201f5add26941100c8a148b96b0a01c1.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">All cases</td><td colspan="2">miRNA-506 expression</td><td rowspan="2"><i>χ</i><sup>2</sup></td><td rowspan="2"><i>p</i>*</td></tr><tr><td>High (<i>n</i> = 60)</td><td>Low (<i>n</i> = 60)</td></tr><tr><td>Age (years)</td><td></td><td></td><td></td><td></td><... | <table><tr><td rowspan="2">Variables</td><td rowspan="2">All cases</td><td>miRNA-506 expression</td></tr><tr><td>High (n = 60)</td></tr><tr><td>Age (years)</td><td></td><td></td></tr><tr><td>≥60</td><td>88</td><td>42</td></tr><tr><td><60</td><td>32</td><td>18</td></tr><tr><td>Gendar</td><td></td><td></td></tr><tr><td>M... | <table><tr><td>miRNA-506 expression</td><td rowspan="2">χ2</td><td rowspan="2">p*</td></tr><tr><td>Low (n = 60)</td></tr><tr><td></td><td></td><td></td></tr><tr><td>46</td><td></td><td></td></tr><tr><td>14</td><td>0.289</td><td>0.409</td></tr><tr><td></td><td></td><td></td></tr><tr><td>45</td><td></td><td></td></tr><tr... |
8fd2fa7d2511770a56cb1a1f86e18c817c4edb3130106b8208781ca681685043.png | simple | <table><tr><td>Participant</td><td>Theme</td><td>Quote</td></tr><tr><td>Female, age 22</td><td>Mitigation</td><td>“Been getting more hypermobile in the last few days, which shows in the results”</td></tr><tr><td>Male, age 41</td><td>Response</td><td>“Feedback is good, I push harder”</td></tr><tr... | <table><tr><td>Participant</td><td>Theme</td><td>Quote</td></tr></table> | <table><tr><td>Female, age 22</td><td>Mitigation</td><td>“Been getting more hypermobile in the last few days, which shows in the results”</td></tr><tr><td>Male, age 41</td><td>Response</td><td>“Feedback is good, I push harder”</td></tr><tr><td></td><td>Mitigation/pain</td><td>“I changed how I was bracing myself and use... |
cd4bbc4a5e247cddb4f073a3d3fbd74c19b47b4ab84426f4fbbe6b57959ac84d.png | complex | <table><tr><td rowspan="3">Variables</td><td colspan="2">High-Sensitivity (<i>n</i> = 23)</td><td colspan="2">Others (<i>n</i> = 34)</td><td rowspan="2"></td></tr><tr><td colspan="2">Female, 78.2%</td><td colspan="2">Female, 50.0%</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td><i>p</i></td></tr><tr><t... | <table><tr><td rowspan="3">Variables</td><td colspan="2">High-Sensitivity (n = 23)</td><td colspan="2">Others (n = 34)</td><td rowspan="2"></td></tr><tr><td colspan="2">Female, 78.2%</td><td colspan="2">Female, 50.0%</td></tr><tr><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>p</td></tr><tr><td>Age (y)</td><td>56.... | <table><tr><td>SF-MPQ Present Pain Intensity</td><td>3.55</td><td>1.26</td><td>3.26</td><td>1.18</td><td>0.40</td></tr></table> |
5b5353f042b2c631bfafc09d4ce43fe1ec3140b8f7a9568e5245346667c5a7a9.png | complex | <table><tr><td>Variable</td><td>Dengue Hemorrhagic Fever (n = 280)</td><td>Dengue Shock Syndrome (n = 11)</td></tr><tr><td></td><td colspan="2">P-value OR (95% CI)</td></tr><tr><td>Presence of bleeding</td><td>0.00070.7 (38.4–129.9)</td><td>0.000608.2 (33.9–1008.9)</td></tr><tr><td>Alanine aminotranferase l... | <table><tr><td>Variable</td><td>Dengue Hemorrhagic Fever (n = 280)</td><td>Dengue Shock Syndrome (n = 11)</td></tr><tr><td></td><td colspan="2">P-value OR (95% CI)</td></tr><tr><td>Presence of bleeding</td><td>0.00070.7 (38.4–129.9)</td><td>0.000608.2 (33.9–1008.9)</td></tr></table> | <table><tr><td>Alanine aminotranferase level</td><td>0.0011.9 (0.97–2.99)</td><td>0.0041.04 (1.015–1.080)</td></tr><tr><td>Aspartate aminotransferase level</td><td>NS</td><td>0.0101.05 (1.012–1.088)</td></tr><tr><td>Urinary Proteins</td><td>0.0431.1 (0.191–1.974)</td><td>NS</td></tr><tr><td>Urinary Red blood cells</td>... |
0dd3e0894f28e772d162e8975f1f064a9319c8e38770286135747e2105218ac3.png | simple | <table><tr><td>Study day</td><td>Date</td><td>Physical examination</td><td>Collar</td><td>Blood</td><td>Skin</td><td>Bone marrow</td></tr><tr><td>Preliminary Screening</td><td>March-April 2012</td><td>+</td><td>-</td><td>+</td><td>-</td><td>-</td></tr><tr><td>Inclusion (D0)</td><td>April-May 2012</td><td>+</td><td>Appl... | <table><tr><td>Study day</td><td>Date</td><td>Physical examination</td><td>Collar</td><td>Blood</td><td>Skin</td><td>Bone marrow</td></tr><tr><td>Preliminary Screening</td><td>March-April 2012</td><td>+</td><td>-</td><td>+</td><td>-</td><td>-</td></tr></table> | <table><tr><td>Inclusion (D0)</td><td>April-May 2012</td><td>+</td><td>Application</td><td>+</td><td>+</td><td>+</td></tr><tr><td>I Follow-up (D90 ± 10)</td><td>July-August 2012</td><td>+</td><td>-</td><td>+</td><td>-</td><td>-</td></tr><tr><td>II Follow-up (D180 ± 10)</td><td>October-November 2012</td><td>+</td><td>-<... |
34519eb34ba9c1bc2ba9195eaae2ffce4d611e59d4a30673f2546ba8ddb9b466.png | complex | <table><tr><td></td><td></td><td colspan="2">Model 3</td><td></td></tr><tr><td>Tree</td><td>CT</td><td>CLADHC</td><td>HT</td><td>SbST</td></tr><tr><td>1</td><td>40.7 <i>(4.7)</i></td><td><underline>54.0</underline><i> (4.5)</i></td><td>42.0 <i>(5.9)</i></td><td>47.5 <i>(4.7)</i></td></tr><tr><td>2</td><td>31.7 <i>(3.4)... | <table><tr><td></td><td></td><td colspan="2">Model 3</td><td></td></tr><tr><td>Tree</td><td>CT</td><td>CLADHC</td><td>HT</td><td>SbST</td></tr><tr><td>1</td><td>40.7 (4.7)</td><td>54.0 (4.5)</td><td>42.0 (5.9)</td><td>47.5 (4.7)</td></tr><tr><td>2</td><td>31.7 (3.4)</td><td>32.7 (3.9)</td><td>43.0 (5.9)</td><td>45.8 (5... | <table><tr><td>10</td><td>5.6 (6.6)</td><td>.1 (4.1)</td><td>.8)</td><td>)</td></tr><tr><td>Average</td><td>37.84 (4.7)</td><td>42.48 (4.4)</td><td>41.9 (6.5)</td><td>44.7 (4.6)</td></tr><tr><td>Std dev.a</td><td>11.07 (0.9)</td><td>7.84 (0.3)</td><td>1.45 (0.7)</td><td>5.94 (0.6)</td></tr></table> |
a718088b1bb7a6d2cd9c973650041a2bcb35560c900f507cd80dcf01e6b80787.png | simple | <table><tr><td>No.</td><td>Age (years)</td><td>Sex</td><td>Employment</td><td>Period of Residence (years)</td><td>Health Status</td><td>Health Effects</td></tr><tr><td>1</td><td>31</td><td>F</td><td>unemployed</td><td>> 15</td><td>A</td><td>not declared</td></tr><tr><td>2</td><td>39</td><td>F</td><td>commerce</td><t... | <table><tr><td>No.</td><td>Age (years)</td><td>Sex</td><td>Employment</td><td>Period of Residence (years)</td></tr><tr><td>1</td><td>31</td><td>F</td><td>unemployed</td><td>> 15</td></tr><tr><td>2</td><td>39</td><td>F</td><td>commerce</td><td>> 5</td></tr><tr><td>3</td><td>40</td><td>F</td><td>unemployed</td><td>> 5</t... | <table><tr><td>Health Status</td><td>Health Effects</td></tr><tr><td>A</td><td>not declared</td></tr><tr><td>D</td><td>gastrointestinal disease, skin hyperpigmentation</td></tr><tr><td>R</td><td>gastrointestinal and respiratory diseases</td></tr><tr><td>R</td><td>skin hyperpigmentation</td></tr><tr><td>R</td><td>gastro... |
bb32d820fdc82c7d82b5214e99dd3da9d0867105ce8d7e3ed699ac127c177bab.png | complex | <table><tr><td rowspan="2"><i>Newborn service</i></td><td colspan="3"><i>Coverage of service (%)</i></td></tr><tr><td><i>Indonesia</i></td><td><i>Lao PDR</i></td><td><i>Philippines</i></td></tr><tr><td>Skilled birth attendance*</td><td>83</td><td>42</td><td>72</td></tr><tr><td>Hep B (first dose)</td><td>85</td><td>37 (... | <table><tr><td rowspan="2">Newborn service</td><td colspan="3">Coverage of service (%)</td></tr><tr><td>Indonesia</td><td>Lao PDR</td><td>Philippines</td></tr><tr><td>Skilled birth attendance*</td><td>83</td><td>42</td><td>72</td></tr><tr><td>Hep </td><td>8</td><td>37 (given at birth</td><td></td></tr></table> | <table><tr><td>B (first dose)</td><td>5</td><td>)</td><td>87</td></tr><tr><td>Hep B (fourth dose)</td><td>41</td><td>56</td><td>67 (third dose)</td></tr><tr><td>BCG vaccination</td><td>89</td><td>78</td><td>92</td></tr><tr><td>Postpartum care for newborn within two days</td><td>48</td><td>47</td><td>not available</td><... |
b51434d5035027198fa237f2dff2ef78f48b2e7e2e25ae8ea2eb5c668f12a3f0.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Experimental (<i>n</i> = 12)</td><td colspan="2">Comparison (<i>n</i> = 8)</td><td rowspan="2"><i>p</i>-Value <sup>b</sup></td></tr><tr><td>Baseline</td><td>10 Weeks</td><td>Baseline</td><td>10 Weeks</td></tr><tr><td>Daily MVPA</td><td>30.7 ± 13.2</td><td>34.2 ±... | <table><tr><td rowspan="2"></td><td colspan="2">Experimental (n = 12)</td><td colspan="2">Comparison (n = 8)</td><td rowspan="2">p-Value b</td></tr><tr><td>Baseline</td><td>10 Weeks</td><td>Baseline</td><td>10 Weeks</td></tr></table> | <table><tr><td>Daily MVPA</td><td>30.7 ± 13.2</td><td>34.2 ± 18.7</td><td>30.2 ± 16.2</td><td>37.8 ± 20.4</td><td>0.49</td></tr><tr><td>Daily LPA</td><td>91.4 ± 28.8</td><td>98.9 ± 29.5</td><td>100.4 ± 31.6</td><td>108.5 ± 47.9</td><td>0.76</td></tr><tr><td>Daily SB</td><td>464.4 ± 50.7</td><td>466.8 ± 34.7</td><td>449... |
87bb39877647a2a174bf54355f586fdafcccbd447bf40c9b97c24ac982b88574.png | complex | <table><tr><td></td><td colspan="4">Quartile of serum calcium level (mg/dL)</td></tr><tr><td></td><td>Q<sub>1</sub></td><td>Q<sub>2</sub></td><td>Q<sub>3</sub></td><td>Q<sub>4</sub></td></tr><tr><td>HR (95% CI)</td><td>(<9.0)</td><td>(9.0 - 9.4)</td><td>(9.4 - 9.8)</td><td>(>9.8)</td></tr><tr><td colspan="2"><i>R... | <table><tr><td></td><td colspan="4">Quartile of serum calcium level (mg/dL)</td></tr><tr><td></td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td></tr><tr><td>HR (95% CI)</td><td>(<9.0)</td><td>(9.0 - 9.4)</td><td>(9.4 - 9.8)</td><td>(>9.8)</td></tr><tr><td colspan="2">Renal replacement therapy</td><td></td><td></td><td></... | <table><tr><td></td><td colspan="4">Quartile of serum calcium level (mg/dL)</td></tr><tr><td></td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td></tr><tr><td>HR (95% CI)</td><td>(<9.0)</td><td>(9.0 - 9.4)</td><td>(9.4 - 9.8)</td><td>(>9.8)</td></tr><tr><td>Model 4</td><td>2.12 (1.49-3.02)*</td><td>1.50 (1.05-2.15)*</td><t... |
6b5e4fcea5f24f49d7e464cf7f1cb4bca4d964fcaa693a8cb86d8bb181bd036c.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">Cell Viability</td></tr><tr><td></td><td>Compound</td><td>Dose</td><td>Human Non-small Cell Lung Cancer</td><td>Normal Diploid Fibroblasts</td></tr><tr><td>X.</td><td>Cyc-[AAAGGGPRGPRPGGGAAA]</td><td>200 μM</td><td>+ + +</td><td>+ + +</td></tr><tr><td>XI.</td><... | <table><tr><td></td><td></td><td></td><td colspan="2">Cell Viability</td></tr><tr><td></td><td>Compound</td><td>Dose</td><td>Human Non-small Cell Lung Cancer</td><td>Normal Diploid Fibroblasts</td></tr><tr><td>X.</td><td>Cyc-[AAAGGGPRGPRPGGGAAA]</td><td>200 μM</td><td>+ + +</td><td>+ + +</td></tr><tr><td>XI.</td><td>Cy... | <table><tr><td>XV</td><td>Linear PRGPRPVALKLALKLAL</td><td>200 μM</td><td>+ + +</td><td>+ + +</td></tr></table> |
6c7414937e32afd5255c6482bf2d31e2998bc792a0ad4b10f261915175c6ffff.png | simple | <table><tr><td>Reference</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr><tr><td>Huang (moderate)<sup>1</sup>[34]</td><td>Higher sales of healthier food options were observed in the intervention group compared to the control group.</td><td></td></tr></table> | <table><tr><td>Reference</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr></table> | <table><tr><td>Huang (moderate)1[34]</td><td>Higher sales of healthier food options were observed in the intervention group compared to the control group.</td></tr></table> |
8b7f724dafd0a23d5cf6a4ea6e0f1d350fc474f5b3c7fa976cff4c2b5f3de6f9.png | simple | <table><tr><td>Work productivity assessment</td><td>No. of patients</td><td>Response, n (%) or mean ± SD</td></tr><tr><td>Employed at baseline</td><td>575</td><td>Yes: 262 (45.6)</td></tr><tr><td>Employed when CD symptoms began</td><td>313</td><td>Yes: 161 (51.4)</td></tr><tr><td>Stopped working due to CD</td><td>... | <table><tr><td>Work productivity assessment</td></tr><tr><td>Employed at baseline</td></tr><tr><td>Employed when CD symptoms began</td></tr><tr><td>Stopped working due to CD</td></tr><tr><td>Employment status affected by CD</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Missed work in past month due to CD</td></t... | <table><tr><td>No. of patients</td><td>Response, n (%) or mean ± SD</td></tr><tr><td>575</td><td>Yes: 262 (45.6)</td></tr><tr><td>313</td><td>Yes: 161 (51.4)</td></tr><tr><td>161</td><td>Yes: 59 (36.6)</td></tr><tr><td>262</td><td>• Different job with less responsibility or pay: 14 (5.3)</td></tr><tr><td></td><td>• Sam... |
295023cea8710dde8a6eb081e1c46faf95b031d6639c412cfca86824c6fea4ee.png | simple | <table><tr><td>Species</td><td>Riparian area</td><td>Forest</td><td>Orchards</td><td>High fallows</td><td>Market gardens</td><td>Village</td></tr><tr><td><i>An. braziliensis</i></td><td>2</td><td>-</td><td>-</td><td>-</td><td>1</td><td>2</td></tr><tr><td><i>An. darlingi</i></td><td>81</td><td>-</td><td>6</td><td>10</td... | <table><tr><td>Species</td><td>Riparian area</td><td>Forest</td><td>Orchards</td><td>High fallows</td><td>Market gardens</td><td>Village</td></tr><tr><td>An. braziliensis</td><td>2</td><td>-</td><td>-</td><td>-</td><td>1</td><td>2</td></tr><tr><td>An. darlingi</td><td>81</td><td>-</td><td>6</td><td>10</td><td>78</td><t... | <table><tr><td>Species</td><td>Riparian area</td><td>Forest</td><td>Orchards</td><td>High fallows</td><td>Market gardens</td><td>Village</td></tr><tr><td>An. triannulatus</td><td>25</td><td>30</td><td>16</td><td>404</td><td>4</td><td>-</td></tr><tr><td>Total</td><td>129</td><td>35</td><td>27</td><td>434</td><td>104</td... |
bf04c3e3cfd5a72e1e3407f417ba709270d8562d70b8cd7e748aafa847177d30.png | simple | <table><tr><td><i>Group</i></td><td><i>n</i></td><td><i>Age (years)</i></td><td><i>Height (cm)</i></td><td><i>Body mass (kg)</i></td></tr><tr><td>AerG</td><td>12</td><td>25 ± 5.6</td><td>176.8 ± 3.8</td><td>74.7 ± 8.2</td></tr><tr><td>ResG</td><td>13</td><td>25 ± 3.5</td><td>175.5 ± 5.6</td><td... | <table><tr><td>Group</td><td>n</td><td>Age (years)</td><td>Height (cm)</td><td>Body mass (kg)</td></tr><tr><td>AerG</td><td>12</td><td>25 ± 5.6</td><td>176.8 ± 3.8</td><td>74.7 ± 8.2</td></tr><tr><td>ResG</td><td>13</td><td>25 ± 3.5</td><td>175.5 ± 5.6</td><td>69.1 ± 8.5</td></tr><tr><td>ConG</td><td>13</td><td>26</td>... | <table><tr><td>Group</td><td>n</td><td>Age (years)</td><td>Height (cm)</td><td>Body mass (kg)</td></tr><tr><td></td><td></td><td> ± 3.1</td><td>8.7 ± 7.0</td><td> ± 12.8</td></tr><tr><td>NonG</td><td>12</td><td>25 ± 2.4</td><td>179.3 ± 11.9</td><td>80.3 ± 12.8</td></tr></table> |
4ccdb038c855c44823522cbc6c51df09d42c2027418e2323267d5203e4105574.png | simple | <table><tr><td>Feature</td><td>Bee</td><td>Fly</td><td>Mosquito</td><td>Moth</td><td>Chafer</td><td>Fruit Fly</td><td>Average Accuracy</td></tr><tr><td>Shape feature</td><td>91.42</td><td>97.67</td><td>98.43</td><td>75.92</td><td>60</td><td>97.05</td><td>86.75</td></tr><tr><td>Texture feature</td><td>78.57</td><td>88.3... | <table><tr><td>Feature</td><td>Bee</td><td>Fly</td><td>Mosquito</td><td>Moth</td><td>Chafer</td><td>Fruit Fly</td><td>Average Accuracy</td></tr><tr><td>Shape feature</td><td>91.42</td><td>97.67</td><td>98.43</td><td>75.92</td><td>60</td><td>97.05</td><td>86.75</td></tr><tr><td>Texture feature</td><td>78.57</td><td>88.3... | <table><tr><td>Feature</td><td>Bee</td><td>Fly</td><td>Mosquito</td><td>Moth</td><td>Chafer</td><td>Fruit Fly</td><td>Average Accuracy</td></tr><tr><td>Global feature</td><td>97.46</td><td>91.83</td><td>94.44</td><td>98.68</td><td>90</td><td>98.68</td><td>95.18</td></tr><tr><td>Global and local feature</td><td>97.46</t... |
20d3f846f0e7fba7368f39275c8ec751fb0ad1b6f28144d1610e8073cf7eef86.png | complex | <table><tr><td rowspan="2">Specimen</td><td colspan="2">Culture</td><td colspan="2">Our Taqman PCR Assay</td></tr><tr><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td></tr><tr><td>Lung (<i>n</i> = 40)</td><td>17</td><td>23</td><td>39</td><td>1</td></tr><tr><td>Milk(<i>n</i> = 18)</td><td>4</td><td>14... | <table><tr><td rowspan="2">Specimen</td><td colspan="2">Culture</td><td colspan="2">Our Taqman PCR Assay</td></tr><tr><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td></tr><tr><td>Lung (n = 40)</td><td>17</td><td>23</td><td>39</td><td>1</td></tr><tr><td>Milk(n = 18)</td><td>4</td><td>14</td><td>4</td... | <table><tr><td>Joint Fluid (n = 3)</td><td>0</td><td>3</td><td>1</td><td>2</td></tr><tr><td>Total (n = 71)</td><td>25</td><td>46</td><td>50</td><td>21</td></tr></table> |
a162839e11fd70366c30cbd231fbe3c2b529e0bf155296969f11b99f51ff55da.png | simple | <table><tr><td>Hose Code</td><td>Shift</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,CCC,*&C,H)H*&,H,HHH,HHH,HHH,CCC/,HHH,HHH,HHH/</td><td>6.89</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&C,C)H*&,C,CC,H=C,HHC/,HHC,*C*C,%N,CC,HHC/</td><td>7.88</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&C,C)H*&,C,C... | <table><tr><td>Hose Code</td><td>Shift</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,CCC,*&C,H)H*&,H,HHH,HHH,HHH,CCC/,HHH,HHH,HHH/</td><td>6.89</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&C,C)H*&,C,CC,H=C,HHC/,HHC,*C*C,%N,CC,HHC/</td><td>7.88</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&C,C)H*&,C,CC,H=C,HHC/,HHC,*C*C,%N,H... | <table><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&C,C)H*&,C,HC,H=C,HHC/,HHC,=OO,HC,HHC/</td><td>6.99</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&C,C)H*&,C,HC,H=C,HHH/,HHH,*C*C,HC/</td><td>7.10</td></tr><tr><td>H-1;C(*C*C/*CC,*CO/*CO,H=C,*&C,C)H*&,C,HC,H=O,HHC/,HHC,*C*C,,HCC/</td><td>7.20</td></tr><tr><td>H-1;C(*C*C/*CC,*CO... |
8db6b64e46341b09b696c55014bcdf6a795d07a898c70e06b7594fdf67d42063.png | simple | <table><tr><td>Factor</td><td>B</td><td>SE</td><td>Wald</td><td>df</td><td>p value</td><td>Odds ratio</td><td>95% CI</td></tr><tr><td>Disturbance to studies: yes</td><td>0.740</td><td>0.366</td><td>4.083</td><td>1</td><td><i>0.043</i></td><td><i>2.1</i></td><td><i>1.1–4.3</i></td></tr><tr><td>Facilities of the cl... | <table><tr><td>Factor</td><td>B</td><td>SE</td><td>Wald</td><td>df</td><td>p value</td><td>Odds ratio</td><td>95% CI</td></tr><tr><td>Disturbance to studies: yes</td><td>0.740</td><td>0.366</td><td>4.083</td><td>1</td><td>0.043</td><td>2.1</td><td>1.1–4.3</td></tr><tr><td>Facilities of the classroom: satisfactory</td><... | <table><tr><td>t from parents: satisfactory</td><td>.800</td><td>8</td><td></td><td></td><td>< 0.001</td><td>.2</td><td>–0.4</td></tr><tr><td>Support from teachers: satisfactory</td><td>− 1.084</td><td>0.449</td><td>5.832</td><td>1</td><td>0.016</td><td>0.3</td><td>0.1–0.8</td></tr><tr><td>Preference of subject stream:... |
91cd47c33a50b6c853e25f8ca82254093f5acd9a70c62431c5b2f5618b95be2c.png | simple | <table><tr><td></td><td><i>n </i>(%)</td><td>Median survival (months)</td><td>95% CI<sup>1</sup></td></tr><tr><td>Died during follow-up</td><td>38 (74.5)</td><td></td><td></td></tr><tr><td>Overall survival (months)</td><td></td><td>10.2</td><td>7.5–13.0</td></tr><tr><td>Gender</td><td>51 (100)</td><td></td><td><i... | <table><tr><td></td><td>n (%)</td><td>Median survival (months)</td><td>95% CI1</td></tr><tr><td>Died during follow-up</td><td>38 (74.5)</td><td></td><td></td></tr><tr><td>Overall survival (months)</td><td></td><td>10.2</td><td>7.5–13.0</td></tr><tr><td>Gender</td><td>51 (100)</td><td></td><td>P = .64</td></tr><tr><td>M... | <table><tr><td></td><td>n (%)</td><td>Median survival (months)</td><td>95% CI1</td></tr><tr><td>Radiographic Response3</td><td>31 (100)</td><td></td><td>P = .21</td></tr><tr><td>Progressive Disease</td><td>7 (22.6)</td><td>13.6</td><td>7.4–19.8</td></tr><tr><td>Stable Disease</td><td>20 (64.5)</td><td>9.3</td><td>6.9–1... |
654914b0d426c9fd4ec415d2562f78c971961646d135794d432e1a7f4cc425c6.png | simple | <table><tr><td>Method</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Cobb</td><td>▪ Simple procedure</td><td>▪ No means to quantify rotation from gradation scheme</td></tr><tr><td></td><td>▪ Little patient exposure to radiation (one anteroposterior radiograph)</td><td>▪ Distortion of ... | <table><tr><td>Method</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Cobb</td><td>▪ Simple procedure</td><td>▪ No means to quantify rotation from gradation scheme</td></tr><tr><td></td><td>▪ Little patient exposure to radiation (one anteroposterior radiograph)</td><td>▪ Distortion of spinous process tip in s... | <table><tr><td>Nash-Moe</td><td>▪ Position of pedicles are less affected by intravertebral rotation; more reliable landmark for measuring rotation</td><td>▪ Provides over-estimation of rotation (can be adjusted by 10° as suggested by Drerup)</td></tr><tr><td></td><td></td><td>▪ Pedicles are poorly visible on vertebrae ... |
e17e8fc8f0bae96a95d3dbeac278a0963edcd1e43189d776cbadc4f6260ac381.png | simple | <table><tr><td>Type</td><td> Male</td><td> Female</td><td> Total</td></tr><tr><td>CO</td><td> 26 (61.9%)</td><td> 16 (38.1%)</td><td> 42</td></tr><tr><td>PP</td><td> 16 (80%)</td><td> 4 (20%)</td><td> 20</td></tr><tr><td>Pl</td><td> 10 (55.6%)</td><td> 8 (44.4%)</td><td> 18</td></tr><tr><td>F/D</td><td> 4 (100%)</td><t... | <table><tr><td>Type</td><td>Male</td><td>Female</td><td>Total</td></tr><tr><td></td><td>26 (</td><td>16 (38</td><td>42</td></tr></table> | <table><tr><td>Type</td><td>Male</td><td>Female</td><td>Total</td></tr><tr><td>CO</td><td>61.9%)</td><td>.1%)</td><td></td></tr><tr><td>PP</td><td>16 (80%)</td><td>4 (20%)</td><td>20</td></tr><tr><td>Pl</td><td>10 (55.6%)</td><td>8 (44.4%)</td><td>18</td></tr><tr><td>F/D</td><td>4 (100%)</td><td>—</td><td>4</td></tr><t... |
5747516d270f3048cc1c1fea11f20b96fd90467f9b08ef07572b64e003d0158d.png | simple | <table><tr><td></td><td>Up-regulated</td><td>Down-regulated</td><td>Total</td></tr><tr><td>Rep1</td><td>90</td><td>86</td><td>176</td></tr><tr><td>Rep2</td><td>77</td><td>89</td><td>166</td></tr><tr><td>Rep1& Rep2</td><td>15</td><td>15</td><td>30</td></tr></table> | <table><tr><td></td><td>Up-regulated</td><td>Down-regulated</td><td>Total</td></tr><tr><td>Rep1</td><td>90</td><td>86</td><td>176</td></tr></table> | <table><tr><td></td><td>Up-regulated</td><td>Down-regulated</td><td>Total</td></tr><tr><td>Rep2</td><td>77</td><td>89</td><td>166</td></tr><tr><td>Rep1& Rep2</td><td>15</td><td>15</td><td>30</td></tr></table> |
d3e199c5e3e62d1baf5dc8e5680956a2a036dfe7a2b4d3a358bc7d1e24f1e085.png | complex | <table><tr><td rowspan="2">Group</td><td rowspan="2">Habituation</td><td>Day 1</td><td>Day 2</td><td>Day 2 - 4</td><td>Day 5 - 8</td><td>Day 9</td><td>Day 9 - 13</td><td>Day 14</td><td>Day 14 - 19</td><td>Day 20</td></tr><tr><td>Stress 1 × 15 min</td><td>Decap</td><td>Stress 2 × 10 min</td><td>Stress 3 ×... | <table><tr><td>Group</td><td>Habituation</td><td>Day 1</td><td>Day 2</td><td>Day 2 - 4</td><td>Day 5 - 8</td><td>Day 9</td><td>Day 9 - 13</td><td>Day 14</td><td>Day 14 - 19</td><td>Day 20</td></tr></table> | <table><tr><td>Group</td><td>Habituation</td><td>Stress 1 × 15 min</td><td>Decap</td><td>Stress 2 × 10 min</td><td>Stress 3 × 10 min</td><td>Decap</td><td>Stress 3 × 10 min</td><td>Decap</td><td>No stress</td><td>Decap</td></tr><tr><td>Stress 1</td><td>V</td><td>V</td><td>V</td><td></td><td></td><td></td><td></td><td><... |
700b87a6daf9760c409a3306707d5c653c5b82a51da2c514c4110723f946916e.png | simple | <table><tr><td>Milestone</td><td>Date</td></tr><tr><td>Review of lower risk drinking guidelines announced</td><td>March 2012</td></tr><tr><td>Expert group assessment of the need to update the guidelines</td><td>2013–2014</td></tr><tr><td>Guidelines development group considered the evidence and produced advice on ... | <table><tr><td>Milestone</td><td>Date</td></tr><tr><td>Review of lower risk drinking guidelines announced</td><td>March 2012</td></tr><tr><td>Expert group assessment of the need to update the guidelines</td><td>2013–2014</td></tr><tr><td>Guidelines development group considered the evidence and produced advice on revisi... | <table><tr><td>Public consultation on the clarity of the guidelines concluded</td><td>April 2016</td></tr><tr><td>Final guidelines released</td><td>August 2016</td></tr></table> |
1535ebea7cf0b5943082a82733ae504d8122950ec9b97b64b0fe986e444969f2.png | simple | <table><tr><td>Drug Name</td><td>Drug Function</td><td>Reference</td></tr><tr><td>Trimetazidine</td><td>Cytoprotective, anti-ischemic</td><td>[78,79]</td></tr><tr><td>Isoflurane</td><td>Cytoprotective</td><td>[80]</td></tr><tr><td>Erythropoietin</td><td>Anti-apoptotic</td><td>[77]</td></tr><tr><td>Deferoxamine:</td><td... | <table><tr><td>Drug Name</td></tr><tr><td>Trimetazidine</td></tr><tr><td>Isoflurane</td></tr><tr><td>Erythropoietin</td></tr><tr><td>Deferoxamine:</td></tr><tr><td>Dimethyloxalylglycine</td></tr><tr><td>Antimycin</td></tr><tr><td>Oxytocin</td></tr><tr><td>Celastrol</td></tr><tr><td>Melatonin</td></tr><tr><td>Nicorandil... | <table><tr><td>Drug Function</td><td>Reference</td></tr><tr><td>Cytoprotective, anti-ischemic</td><td>[78,79]</td></tr><tr><td>Cytoprotective</td><td>[80]</td></tr><tr><td>Anti-apoptotic</td><td>[77]</td></tr><tr><td>HIF-1α stabilizer</td><td>[81,82]</td></tr><tr><td>HIF-1α stabilizer</td><td>[83]</td></tr><tr><td>Mito... |
1a25c6896836c430c0c07bba6513fc360e8f36aa7a32c56ab467dd62dcf88503.png | complex | <table><tr><td>Study*</td><td>30-day major complications</td><td>30-day minor complications</td><td>Pulmonary embolism</td><td>Deep venous thrombosis</td><td>Readmissions in the first 30 postoperative days</td></tr><tr><td>Abdalla [15]</td><td>1</td><td>5</td><td>0</td><td>0</td><td>NR<sup>1</sup></td></tr><tr><td>Buch... | <table><tr><td>Study*</td><td>30-day major complications</td><td>30-day minor complications</td><td>Pulmonary embolism</td><td>Deep venous thrombosis</td><td>Readmissions in the first 30 postoperative days</td></tr><tr><td>Abdalla [15]</td><td>1</td><td>5</td><td>0</td><td>0</td><td>NR1</td></tr><tr><td>Buchs [16]</td>... | <table><tr><td>Vilallonga [18]</td><td>1 case</td><td>NR</td><td>NR</td><td>NR</td><td>NR</td></tr><tr><td>Ayloo [19]</td><td colspan="2">NR</td><td>NR</td><td>NR</td><td>0</td></tr><tr><td>Diamantis [20]</td><td colspan="2">0 (not classified)</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Edelson [21]</td><td colspan=... |
c9690a1275fcca362d19cd94c8d4761684d7f45e7ac1ffd917e1cda50aa4defe.png | simple | <table><tr><td>Step</td><td>Predictor variable</td><td>Δ<i>F</i></td><td><i>R</i><sup>2</sup></td><td>Δ<i>R</i><sup>2</sup></td><td>ß</td><td><i>p</i></td></tr><tr><td></td><td>OVERALL</td></tr><tr><td>1</td><td>Age</td><td>19.065</td><td>0.238</td><td>–</td><td>−0.413</td><td>0.001</td></tr>... | <table><tr><td>Step</td><td>Predictor variable</td><td>ΔF</td><td>R2</td><td>ΔR2</td><td>ß</td><td>p</td></tr><tr><td></td><td>OVERALL</td><td colspan="5"></td></tr><tr><td>1</td><td>Age</td><td>19.065</td><td>0.238</td><td>–</td><td>−0.413</td><td>0.001</td></tr><tr><td></td><td>Sex</td><td>–</td><td>–</td><td>–</td><... | <table><tr><td></td><td>BDI score</td><td>522</td><td>2</td><td>05</td><td>−0.077</td><td>472</td></tr><tr><td></td><td>MALES</td><td colspan="5"></td></tr><tr><td>1</td><td>Age</td><td>10.376</td><td>0.206</td><td>–</td><td>−0.454</td><td>0.003</td></tr><tr><td>2</td><td>BDI score</td><td>25.059</td><td>0.517</td><td>... |
158a8e76239fa396f07e48d9c4ca5e5da6fc687eba197df1013a06c4a46f32ca.png | simple | <table><tr><td>Variable</td><td>N(%) = 604(100%)</td></tr><tr><td>Gender (male)</td><td>417(69%)</td></tr><tr><td>Age (yrs)</td><td>60.2(± 12.5)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>26.5(24.3-29.4)</td></tr><tr><td>Race (Caucasian)</td><td>560(92.7)</td></tr><tr><td>Cause of CKD</td><td></td></tr><tr><t... | <table><tr><td>Variable</td><td>N(%) = 604(100%)</td></tr><tr><td>Gender (male)</td><td>417(69%)</td></tr><tr><td>Age (yrs)</td><td>60.2(± 12.5)</td></tr><tr><td>BMI (kg/m2)</td><td>26.5(24.3-29.4)</td></tr><tr><td>Race (Caucasian)</td><td>560(92.7)</td></tr><tr><td>Cause of CKD</td><td></td></tr><tr><td>Diabetic nephr... | <table><tr><td>iabetes Mellitus</td><td>3.8%)</td></tr><tr><td>Hypertension</td><td>433(71.7%)</td></tr><tr><td>Smoking</td><td>145(24%)</td></tr><tr><td>Systolic BP (mmHg)</td><td>136(± 21)</td></tr><tr><td>Diastolic BP (mmHg)</td><td>78(± 11)</td></tr><tr><td>Creatinine (μmol/l)</td><td>184(± 71)</td></tr><tr><td>eGF... |
22888166946b2b65769cc39e736cacb82becafa38d3ce9675a39997e6cae4f44.png | complex | <table><tr><td><i>IFN</i>-<i>γ</i>-1616 T/C Genotypes</td><td>OR<sup>‡</sup>(95% CI)</td><td><i>P</i>value</td></tr><tr><td>TT</td><td>5.53 (2.30- 13.27)</td><td><0.001</td></tr><tr><td>TC</td><td>1.00</td><td></td></tr><tr><td>CC</td><td>0.65 (0.15- 2.80)</td><td>0.56</td></tr><tr><td>Alleles frequency</... | <table><tr><td>IFN-γ-1616 T/C Genotypes</td><td>OR‡(95% CI)</td><td>Pvalue</td></tr><tr><td>TT</td><td>5.53 (2.30- 13.27)</td><td><0.001</td></tr><tr><td>TC</td><td>1.00</td><td></td></tr><tr><td>CC</td><td>0.65 (0.15- 2.80)</td><td>0.56</td></tr><tr><td>Alleles frequency</td><td></td><td></td></tr><tr><td>T</td><td>0.... | <table><tr><td>IFN-γ-1616 T/C Genotypes</td><td>OR‡(95% CI)</td><td>Pvalue</td></tr><tr><td>C</td><td>0.28 (0.10- 0.76)</td><td>0.008</td></tr></table> |
acc02e96550368d8e968e4ad25560aacfaef996e72b01d524dca0bc7c6e1b92a.png | simple | <table><tr><td>Time (years)</td><td>Transformation rate</td><td>Standard error</td><td>95% confidence interval</td></tr><tr><td>1</td><td>0.0119</td><td>0.0015</td><td>0.0093-0.0154</td></tr><tr><td>2</td><td>0.0232</td><td>0.0022</td><td>0.0192-0.0279</td></tr><tr><td>3</td><td>0.0290</td><td>0.0025</td><td>0.0244-0.0... | <table><tr><td>Time (years)</td><td>Transformation rate</td><td>Standard error</td></tr><tr><td>1</td><td>0.0119</td><td>0.0015</td></tr><tr><td>2</td><td>0.0232</td><td>0.0022</td></tr><tr><td>3</td><td>0.0290</td><td>0.0025</td></tr><tr><td>4</td><td>0.0385</td><td>0.0030</td></tr><tr><td>5</td><td>0.0461</td><td>0.0... | <table><tr><td>95% confidence interval</td></tr><tr><td>0.0093-0.0154</td></tr><tr><td>0.0192-0.0279</td></tr><tr><td>0.0244-0.0343</td></tr><tr><td>0.0329-0.0449</td></tr><tr><td>0.0398-0.0534</td></tr><tr><td>0.0471-0.0624</td></tr><tr><td>0.0517-0.0681</td></tr><tr><td>0.0535-0.0706</td></tr><tr><td>0.0578-0.0773</t... |
be92e4811f9c78a9f65f876505e35ba04ec7a665ee457729cf6e08345e2f8807.png | simple | <table><tr><td>Receptor</td><td>Ligand 7</td><td>Ligand 11</td><td>Ligand 15</td></tr><tr><td>CA-II</td><td>6</td><td>0</td><td>5</td></tr><tr><td>Cat B</td><td>8</td><td>1</td><td>3</td></tr><tr><td>DNA-1</td><td>5</td><td>2</td><td>7</td></tr><tr><td>DNA-2</td><td>2</td><td>2</td><td>5</td></tr><tr><td>Gyrase</td><td... | <table><tr><td>Receptor</td></tr><tr><td>CA-II</td></tr><tr><td>Cat B</td></tr><tr><td>DNA-1</td></tr><tr><td>DNA-2</td></tr><tr><td>Gyrase</td></tr><tr><td>HDAC7</td></tr><tr><td>HIS</td></tr><tr><td>Kinase</td></tr><tr><td>rHA</td></tr><tr><td>RNR</td></tr><tr><td>Top II</td></tr><tr><td>TrxR</td></tr><tr><td>TS</td>... | <table><tr><td>Ligand 7</td><td>Ligand 11</td><td>Ligand 15</td></tr><tr><td>6</td><td>0</td><td>5</td></tr><tr><td>8</td><td>1</td><td>3</td></tr><tr><td>5</td><td>2</td><td>7</td></tr><tr><td>2</td><td>2</td><td>5</td></tr><tr><td>3</td><td>1</td><td>6</td></tr><tr><td>3</td><td>0</td><td>3</td></tr><tr><td>4</td><td... |
0649c8d3475dc9d567946a1107ba0d00cb9b3b866d3947094e672277b57cbb2f.png | complex | <table><tr><td></td><td colspan="2">Number of</td><td></td><td colspan="2">Number of</td></tr><tr><td>Condition</td><td>Trials</td><td>Patients</td><td>Drug treaments</td><td>Trial arms</td><td>Contributing patients</td></tr><tr><td>Arthritis</td><td>16</td><td>2990</td><td>Opioid</td><td>24</td><td>2173</td></tr><tr><... | <table><tr><td></td><td colspan="2">Number of</td><td></td><td colspan="2">Number of</td></tr><tr><td>Condition</td><td>Trials</td><td>Patients</td><td>Drug treaments</td><td>Trial arms</td><td>Contributing patients</td></tr><tr><td>Arthritis</td><td>16</td><td>2990</td><td>Opioid</td><td>24</td><td>2173</td></tr><tr><... | <table><tr><td></td><td></td><td></td><td>Placebo</td><td>4</td><td>302</td></tr><tr><td></td><td></td><td></td><td>Other comparator</td><td>0</td><td>0</td></tr><tr><td>Neuropathic</td><td>5</td><td>302</td><td>Opioid</td><td>5</td><td>219</td></tr><tr><td></td><td></td><td></td><td>Placebo</td><td>4</td><td>178</td><... |
3198d29452e25533d50bce0be8469c86ba4093fcf9c002782258b0b561b09d39.png | simple | <table><tr><td>Sub-groups</td><td>T1DM patients (<i>N</i> = 216)</td><td>Controls (<i>N</i> = 204)</td><td><i>p</i>-value</td><td>OR<sup>a</sup></td><td>CI<sup>b</sup></td></tr><tr><td>Deficient</td><td>182 (84 %)</td><td>158 (77 %)</td><td>0.046</td><td>1.66</td><td>1.02–2.701</td></tr><tr><td>Insufficient</td><... | <table><tr><td>Sub-groups</td><td>T1DM patients (N = 216)</td><td>Controls (N = 204)</td><td>p-value</td><td>ORa</td><td>CIb</td></tr></table> | <table><tr><td>Deficient</td><td>182 (84 %)</td><td>158 (77 %)</td><td>0.046</td><td>1.66</td><td>1.02–2.701</td></tr><tr><td>Insufficient</td><td>31 (15 %)</td><td>29 (14 %)</td><td>0.93</td><td>0.977</td><td>0.565–1.689</td></tr><tr><td>Sufficient</td><td>3 (1 %)</td><td>11 (5 %)</td><td>0.027</td><td>0.239</td><td>0... |
6436a10cb29bc91a618cdf1e8da0399578de9da87de9dfd786b05507afd23911.png | simple | <table><tr><td>Participants</td><td>Gender</td><td>Years of implant</td><td>Etiology</td><td>Implantation site</td></tr><tr><td>F.R.</td><td>M</td><td>9</td><td>Neurofibratosis type 2</td><td>Brainstem</td></tr><tr><td>D.M.</td><td>M</td><td>13</td><td>Trauma with bilateral cochlear fracture</td><td>Brainstem</td></tr>... | <table><tr><td>Participants</td><td>Gender</td></tr><tr><td>F.R.</td><td>M</td></tr><tr><td>D.M.</td><td>M</td></tr><tr><td>M.A.</td><td>F</td></tr><tr><td>P.S.</td><td>M</td></tr><tr><td>M.G.</td><td>M</td></tr><tr><td>G.A.</td><td>F</td></tr></table> | <table><tr><td>Years of implant</td><td>Etiology</td><td>Implantation site</td></tr><tr><td>9</td><td>Neurofibratosis type 2</td><td>Brainstem</td></tr><tr><td>13</td><td>Trauma with bilateral cochlear fracture</td><td>Brainstem</td></tr><tr><td>16</td><td>Congenital hearing loss</td><td>Cochlea</td></tr><tr><td>15</td... |
39d37e67af8c377f9618160b041ce098e1d1568fd0b3c9d2b1acd9ccb8755184.png | complex | <table><tr><td> </td><td colspan="5">Boys</td><td colspan="5">Girls</td></tr><tr><td> </td><td colspan="2"><11 years</td><td colspan="2">≥11 years</td><td> </td><td colspan="2"><10 years</td><td colspan="2">≥10 years</td><td> </td></tr><tr><td> </td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)<... | <table><tr><td></td><td colspan="4">Boys</td></tr><tr><td></td><td colspan="2"><11 years</td><td colspan="2">≥11 years</td></tr><tr><td></td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td></tr><tr><td>Y1</td><td>32</td><td>0.53 (0.36)</td><td>22</td><td>0.24 (0.34)</td></tr><tr><td>Y2</td><td>25</td><td>0.94 (... | <table><tr><td>Boys</td><td colspan="5">Girls</td></tr><tr><td></td><td colspan="2"><10 years</td><td colspan="2">≥10 years</td><td></td></tr><tr><td>P value</td><td>N</td><td>Mean (SD)</td><td>N</td><td>Mean (SD)</td><td>P value</td></tr><tr><td>0.0046</td><td>12</td><td>0.42 (0.51)</td><td>10</td><td>0.29 (0.38)</td>... |
492335f8678281b22ee1e5f3e86b8fd1eff138a3a1f798f62974df3b42989680.png | complex | <table><tr><td>Variables</td><td>b (SE)</td><td>Beta</td><td>p-value</td></tr><tr><td>Intercept</td><td>14.71</td><td colspan="2"></td></tr><tr><td>Pain (VAS)</td><td>0.77 (0.35)</td><td>0.31</td><td>0.03</td></tr><tr><td>Gender (female vs male)</td><td>6.48 (2.00)</td><td>0.39</td><td>0.00</td></tr><tr><td>Age (years)... | <table><tr><td>Variables</td><td>b (SE)</td><td>Beta</td><td>p-value</td></tr><tr><td>Intercept</td><td>14.71</td><td colspan="2"></td></tr><tr><td>Pain (VAS)</td><td>0.77 (0.35)</td><td>0.31</td><td>0.03</td></tr><tr><td>Gender (female vs male)</td><td>6.48 (2.00)</td><td>0.39</td><td>0.00</td></tr><tr><td>Age (years)... | <table><tr><td>Maximum walking speed (m/s)</td><td>9.59 (3.54)</td><td>0.41</td><td>0.01</td></tr><tr><td></td><td colspan="3">R2 = 0.47 p < 0.001</td></tr></table> |
ea7dea7c717d3cfc962baa9db64c1b0b969e18fd43c7ef75e8640c3c2cece9f9.png | simple | <table><tr><td>Gene symbol</td><td>Description</td><td>Log<sub>2</sub>FC</td><td><i>P</i><sub>adjusted</sub></td></tr><tr><td><i>FLAI-K-feline</i></td><td><i>Feline class I antigen-alpha chain-like class I antigen</i></td><td><i>1.7066</i></td><td>4.95E−06*</td></tr><tr><td><i>LOC101084108</i></td><td>HLA class I... | <table><tr><td>Gene symbol</td><td>Description</td><td>Log2FC</td><td>Padjusted</td></tr><tr><td>FLAI-K-feline</td><td>Feline class I antigen-alpha chain-like class I antigen</td><td>1.7066</td><td>4.95E−06*</td></tr><tr><td>LOC101084108</td><td>HLA class II histocompatibility antigen, DM alpha chain</td><td>0.24295</t... | <table><tr><td>LOC101088734</td><td>HLA class II histocompatibility antigen DR alpha chain-like</td><td>−0.63486</td><td>0.24216</td></tr><tr><td>HMHA1</td><td>Minor human histocompatibility protein HA-1</td><td>−0.67421</td><td>0.0512</td></tr></table> |
1722f77feea4598a54484e30800addc7c374b96e1dd9b576fb46f9f9ca1bfa8a.png | simple | <table><tr><td><i>Immunophenotypic marker</i></td><td><i>MLL rearrangement (n = 11)</i></td><td><i>Hyperdiploidy (n = 34)</i></td><td><i>t (12;21) (n = 21)</i></td><td><i>t (1;19) (n = 5)</i></td><td><i>Rare (n = 8)</i></td><td><i>Normal karyotype (n = 28)</i></td><td>Total (n = 107)*</td><td>p-Value</td></tr><tr><td>C... | <table><tr><td>Immunophenotypic marker</td><td>MLL rearrangement (n = 11)</td><td>Hyperdiploidy (n = 34)</td><td>t (12;21) (n = 21)</td><td>t (1;19) (n = 5)</td><td>Rare (n = 8)</td></tr><tr><td>CD10</td><td>27%(3/11§)</td><td>53%(18/34)</td><td>67%(14/21)</td><td>80%(4/5)</td><td>63%(5/8)</td></tr><tr><td>CD33</td><td... | <table><tr><td>Normal karyotype (n = 28)</td><td>Total (n = 107)*</td><td>p-Value</td></tr><tr><td>50%(14/28)</td><td>58%(62/107)</td><td>ns</td></tr><tr><td>42%(10/24)</td><td>33%(32/97)</td><td>ns</td></tr><tr><td>7%(2/27)</td><td>17%(17/102)</td><td>ns</td></tr><tr><td>7%(2/28)</td><td>8.8%(10/114)</td><td>ns</td></... |
7baf7b539ab663981c131792096aa84c133b51f74a13385189e89a45a619dbc9.png | complex | <table><tr><td rowspan="2">Clinicopathological features</td><td rowspan="2">N</td><td colspan="2">STK31 methylation</td><td rowspan="2">p</td></tr><tr><td>+</td><td>-</td></tr><tr><td>Age</td><td>148</td><td></td><td></td><td></td></tr><tr><td><45</td><td></td><td>49</td><td>13</td><td>0.741</td></tr><tr><td>≥... | <table><tr><td rowspan="2">Clinicopathological features</td><td rowspan="2">N</td><td colspan="2">STK31 methylation</td><td rowspan="2">p</td></tr><tr><td>+</td><td>-</td></tr><tr><td>Age</td><td>148</td><td></td><td></td><td></td></tr><tr><td><45</td><td></td><td>49</td><td>13</td><td>0.741</td></tr><tr><td>≥45</td><t... | <table><tr><td rowspan="2">Clinicopathological features</td><td rowspan="2">N</td><td colspan="2">STK31 methylation</td><td rowspan="2">p</td></tr><tr><td>+</td><td>-</td></tr><tr><td>ifferentiation</td><td>146</td><td></td><td></td><td></td></tr><tr><td>Well + Moderate</td><td></td><td>75</td><td>17</td><td>0.584</td>... |
96358570a2041c6494fe5cd72f0256604fe3b139e2a9b1b54902fa5c80e0121f.png | complex | <table><tr><td colspan="2">Recommendation</td><td>Quality of evidence</td><td>Strength of recommendation</td><td>Rationale (Benefits, harms and the preferences of patients and clinicians)</td></tr><tr><td>1</td><td>Victims with potential spinal injury should have spinal stabilisation.</td><td>Very low</td><td>Strong</t... | <table><tr><td colspan="2">Recommendation</td><td>Quality of evidence</td><td>Strength of recommendation</td><td>Rationale (Benefits, harms and the preferences of patients and clinicians)</td></tr><tr><td>1</td><td>Victims with potential spinal injury should have spinal stabilisation.</td><td>Very low</td><td>Strong</t... | <table><tr><td>8</td><td>Patients with potential spinal injury should be transported strapped supine on a vacuum mattress or on an ambulance stretcher system.</td><td>Very low</td><td>Conditional</td><td>Evidence supporting harm from hard surface stretcher systems. No consistent evidence demonstrating increased stabili... |
6606ab586111301841830ae53e171d342e9289b684fbbdfbe0e7c4e08a3012d2.png | simple | <table><tr><td><i>x</i><sub>1</sub></td><td><i>x</i><sub>2</sub></td><td><i>x</i><sub>3</sub></td><td><i>x</i><sub>4</sub></td><td><i>x</i><sub>5</sub></td><td><i>x</i><sub>6</sub></td></tr><tr><td>.688</td><td>.352</td><td>−.083</td><td>.096</td><td>−.301</td><td>−.105</td></tr><tr><td>.733</td><td>.... | <table><tr><td>x1</td><td>x2</td><td>x3</td><td>x4</td></tr><tr><td>.688</td><td>.352</td><td>−.083</td><td>.096</td></tr><tr><td>.733</td><td>.352</td><td>.104</td><td>−.176</td></tr><tr><td>.856</td><td>−.167</td><td>−.204</td><td>.208</td></tr><tr><td>.709</td><td>−.405</td><td>−.357</td><td>−.210</td></tr><tr><td>.... | <table><tr><td>x5</td><td>x6</td></tr><tr><td>−.301</td><td>−.105</td></tr><tr><td>.087</td><td>−.411</td></tr><tr><td>.006</td><td>−.123</td></tr><tr><td>−.085</td><td>.019</td></tr><tr><td>−.025</td><td>.254</td></tr><tr><td>.318</td><td>−.100</td></tr><tr><td>−.259</td><td>−.054</td></tr><tr><td>−.109</td><td>.410</... |
16c08e0c19f15545da6fecc55af765cf2d0e79b36a4bf669db6d0f5a2daa6e4d.png | simple | <table><tr><td>Target</td><td>Efficiency LNA primers</td><td>Efficiency DNA primers</td><td>Difference</td></tr><tr><td>let-7a</td><td>82%</td><td>89%</td><td>6.9%</td></tr><tr><td>miR-101a</td><td>85%</td><td>90%</td><td>4.9%</td></tr><tr><td>miR-103</td><td>93%</td><td>94%</td><td>1.6%</td></tr><tr><td>miR-122</td><t... | <table><tr><td>Target</td><td>Efficiency LNA primers</td><td>Efficiency DNA primers</td></tr><tr><td>let-7a</td><td>82%</td><td>89%</td></tr><tr><td>miR-101a</td><td>85%</td><td>90%</td></tr><tr><td>miR-103</td><td>93%</td><td>94%</td></tr><tr><td>miR-122</td><td>95%</td><td>95%</td></tr><tr><td>miR-125b</td><td>89%</t... | <table><tr><td>Difference</td></tr><tr><td>6.9%</td></tr><tr><td>4.9%</td></tr><tr><td>1.6%</td></tr><tr><td>-0.1%</td></tr><tr><td>4.5%</td></tr><tr><td>6.4%</td></tr><tr><td>12.6%</td></tr><tr><td>7.1%</td></tr><tr><td>-2.0%</td></tr><tr><td>13.6%</td></tr><tr><td>0.2%</td></tr><tr><td>1.1%</td></tr><tr><td>14.1%</td... |
6286007f859fe05e6e07a0b9bed07f872836b86f5df1de6f036eb14ec9df53f2.png | complex | <table><tr><td></td><td colspan="2">P1</td><td colspan="2">N1</td><td colspan="2">P2</td></tr><tr><td></td><td>Control</td><td>Patient</td><td>Control</td><td>Patient</td><td>Control</td><td>Patient</td></tr><tr><td colspan="7">AVERAGE AMPLITUDE</td></tr><tr><td>Standard</td><td>0.281</td><td>0.463</td><td>0.290</td><t... | <table><tr><td></td><td colspan="2">P1</td></tr><tr><td></td><td>Control</td><td>Patient</td></tr><tr><td colspan="3">AVERAGE AMPLITUDE</td></tr><tr><td>Standard</td><td>0.281</td><td>0.463</td></tr><tr><td>Low deviant</td><td>0.324</td><td>0.337</td></tr><tr><td>High deviant</td><td>−0.080</td><td>0.219</td></tr><tr><... | <table><tr><td colspan="2">N1</td><td colspan="2">P2</td></tr><tr><td>Control</td><td>Patient</td><td>Control</td><td>Patient</td></tr><tr><td colspan="4">AVERAGE AMPLITUDE</td></tr><tr><td>0.290</td><td>0.031</td><td>0.552</td><td>0.635</td></tr><tr><td>−0.941</td><td>−0.468</td><td>0.705</td><td>0.812</td></tr><tr><t... |
dc14599f76f6a7c7a8ff2363abc40227cf1b64021a6a3c890500cfd5b1798842.png | simple | <table><tr><td>Nutrient</td><td>Oxygen (kJ/l)</td><td>Carbon dioxide (kJ/l)</td></tr><tr><td>Carbohydrate</td><td>21.1</td><td>21.1</td></tr><tr><td>Protein</td><td>18.7</td><td>23.4</td></tr><tr><td>Fat</td><td>19.6</td><td>27.8</td></tr></table> | <table><tr><td>Nutrient</td><td>Oxygen (kJ/l)</td></tr><tr><td>Carbohydrate</td><td>21.1</td></tr><tr><td>Protein</td><td>18.7</td></tr><tr><td>Fat</td><td>19.6</td></tr></table> | <table><tr><td>Carbon dioxide (kJ/l)</td></tr><tr><td>21.1</td></tr><tr><td>23.4</td></tr><tr><td>27.8</td></tr></table> |
146939c099484ec3dd533e85bb97f349b3068504e3e58abca78c036a5f9ae10f.png | simple | <table><tr><td>Activities</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>1</td><td>0.000</td><td>0.039</td><td>0.007</td><td>0.154</td><td>0.357</td><td>0.405</td><td>0.194</td><td>0.090</td></tr><tr><td>2</td><td>0.039</td><td>0.000</td><td>0.032</td><td>0.115</td><td>... | <table><tr><td>Activities</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>1</td><td>0.000</td><td>0.039</td><td>0.007</td><td>0.154</td><td>0.357</td><td>0.405</td><td>0.194</td><td>0.090</td></tr><tr><td>2</td><td>0.039</td><td>0.000</td><td>0.032</td><td>0.115</td><td>... | <table><tr><td>Activities</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>7</td><td>0.194</td><td>0.233</td><td>0.200</td><td>0.347</td><td>0.163</td><td>0.212</td><td>0.000</td><td>0.103</td></tr><tr><td>8</td><td>0.090</td><td>0.129</td><td>0.097</td><td>0.244</td><td>... |
07ab9cb393a30b215487f71f80bce778b247eecb3f74beb70fc784a368801eeb.png | complex | <table><tr><td rowspan="2">Spiked conc.(μg/ml)</td><td colspan="3">Between-day assay (n=6)</td><td colspan="3">Within-day assay (n=6)</td></tr><tr><td>Mean</td><td>SD</td><td>RSD (%)</td><td>Mean</td><td>SD</td><td>RSD (%)</td></tr><tr><td>5 </td><td>5.9</td><td>0.5</td><td>8.5</td><td>5.4</td><td>0.9</td><td>16.7... | <table><tr><td rowspan="2">Spiked conc.(μg/ml)</td><td colspan="3">Between-day assay (n=6)</td><td colspan="3">Within-day assay (n=6)</td></tr><tr><td>Mean</td><td>SD</td><td>RSD (%)</td><td>Mean</td><td>SD</td><td>RSD (%)</td></tr></table> | <table><tr><td>5</td><td>5.9</td><td>0.5</td><td>8.5</td><td>5.4</td><td>0.9</td><td>16.7</td></tr><tr><td>50</td><td>49.8</td><td>4.5</td><td>11</td><td>52.4</td><td>5.6</td><td>10.7</td></tr><tr><td>200</td><td>217.2</td><td>21.7</td><td>10.0</td><td>217.2</td><td>26.6</td><td>12.2</td></tr></table> |
f314212f46129079a45835c178a7031ba5f369c63e6acaaf9ee078eb86052309.png | simple | <table><tr><td></td><td>PM (n = 11)</td><td>DM (n = 38)</td><td>Total (n = 49)</td></tr><tr><td>Age at diagnosis (years)†</td><td>51.1 ± 15.8</td><td>43.7 ± 13.9</td><td>45.4 ± 14.6</td></tr><tr><td>Gender (F:M)</td><td>7:4</td><td>23:15</td><td>30:19</td></tr><tr><td>Disease duration (months)̶... | <table><tr><td></td><td>PM (n = 11)</td><td>DM (n = 38)</td><td>Total (n = 49)</td></tr><tr><td>Age at diagnosis (years)†</td><td>51.1 ± 15.8</td><td>43.7 ± 13.9</td><td>45.4 ± 14.6</td></tr><tr><td>Gender (F:M)</td><td>7:4</td><td>23:15</td><td>30:19</td></tr></table> | <table><tr><td>Disease duration (months)†</td><td>44.2 ± 46.9</td><td>62.9 ± 53.0</td><td>59.1 ± 51.9</td></tr><tr><td>Clinical manifestation, n (%)</td><td></td><td></td><td></td></tr><tr><td>Fever</td><td>3 (27.3)</td><td>11 (28.9)</td><td>14 (28.6)</td></tr><tr><td>Raynaud's phenomenon</td><td>2 (18.2)</td><td>6 (15... |
7a102ec52d90d4b74928cebc2c2ea87377207509a87fe0b674b99a0118701ff5.png | complex | <table><tr><td colspan="2">Total particles (by optical particle counter)</td><td colspan="4">Viral particles (by RT-PCR analysis)</td></tr><tr><td rowspan="2">Particle size range (μm)</td><td rowspan="2">Average removal efficiency (%)</td><td rowspan="2">Particle size range (μm)</td><td colspan="3">Average re... | <table><tr><td colspan="2">Total particles (by optical particle counter)</td><td colspan="4">Viral particles (by RT-PCR analysis)</td></tr><tr><td rowspan="2">Particle size range (μm)</td><td rowspan="2">Average removal efficiency (%)</td><td rowspan="2">Particle size range (μm)</td><td colspan="3">Average removal effi... | <table><tr><td>0.3–0.5</td><td>51.6</td><td>0.4–0.7</td><td>77.1</td><td>98.4</td><td>89.9</td></tr><tr><td>0.5–1.0</td><td>56.1</td><td>0.7–1.1</td><td>52</td><td>–a</td><td>95.5</td></tr><tr><td>1.0–3.0</td><td>76.2</td><td>1.1–2.1</td><td>77.7</td><td>–</td><td>58.8</td></tr><tr><td>3.0–5.0</td><td>82.2</td><td>2.1–... |
38ac12af0f4e45278aedfd4f26964f4915d629d8eec21d1596c115fe120f0906.png | complex | <table><tr><td> </td><td>Training</td><td>Tuning</td><td>Testing</td></tr><tr><td colspan="4">French</td></tr><tr><td>Titles</td><td>458,543</td><td>57,317</td><td>57,317</td></tr><tr><td>Abstracts (hr=0.0)</td><td>28,882</td><td>28,882</td><td>28,881</td></tr><tr><td>Abstracts (hr=0.29)</td><td>17,351</td><td>17,365</... | <table><tr><td></td></tr><tr><td>French</td></tr><tr><td>Titles</td></tr><tr><td>Abstracts (hr=0.0)</td></tr><tr><td>Abstracts (hr=0.29)</td></tr><tr><td>Spanish</td></tr><tr><td>Titles</td></tr><tr><td>Abstracts (hr=0.0)</td></tr><tr><td>Abstracts (hr=0.29)</td></tr></table> | <table><tr><td>Training</td><td>Tuning</td><td>Testing</td></tr><tr><td colspan="3">French</td></tr><tr><td>458,543</td><td>57,317</td><td>57,317</td></tr><tr><td>28,882</td><td>28,882</td><td>28,881</td></tr><tr><td>17,351</td><td>17,365</td><td>28,881</td></tr><tr><td colspan="3">Spanish</td></tr><tr><td>198,512</td>... |
fdbd617074428e0d609bf0a0f7812a56c299b45f1a2e88d9ba260004051f4f90.png | complex | <table><tr><td>Demographic variable</td><td></td><td>Pre (N = 88)</td><td colspan="2">Post (N = 69)</td><td></td></tr><tr><td></td><td></td><td>n (%)</td><td colspan="2">n (%)</td><td>Test statistics</td></tr><tr><td rowspan="2">Gender</td><td>Female</td><td>63(72)</td><td colspan="2">53(77)</td><td>x2 = 0.546, <i>df</... | <table><tr><td>Demographic variable</td><td></td><td>Pre (N = 88)</td><td colspan="2">Post (N = 69)</td><td></td></tr><tr><td></td><td></td><td>n (%)</td><td colspan="2">n (%)</td><td>Test statistics</td></tr><tr><td rowspan="2">Gender</td><td>Female</td><td>63(72)</td><td colspan="2">53(77)</td><td>x2 = 0.546, df = 1,... | <table><tr><td rowspan="4">Current unit*</td><td></td><td>[n = 76]</td><td colspan="2">[n = 58]</td><td>x2 = 3.469, df = 2, p = 0.176</td></tr><tr><td>Private ICU</td><td>25(33)</td><td colspan="2">17(29)</td><td></td></tr><tr><td>General ICU</td><td>32(42)</td><td colspan="2">18(31)</td><td></td></tr><tr><td>Cardiotho... |
360747d8f3f118be1590577c409365fa5692af8e35ab1fed492c31b4b9913c21.png | complex | <table><tr><td></td><td></td><td colspan="2">Wheeze</td><td colspan="2">Asthma</td><td colspan="2">Eczema</td><td colspan="2">Rhinoconjunctivitis</td></tr><tr><td></td><td>N</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Smoking status</td><td></td><td></td><td></td><td... | <table><tr><td></td><td></td><td colspan="2">Wheeze</td><td colspan="2">Asthma</td><td colspan="2">Eczema</td><td colspan="2">Rhinoconjunctivitis</td></tr><tr><td></td><td>N</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Smoking status</td><td></td><td></td><td></td><td... | <table><tr><td></td><td></td><td colspan="2">Wheeze</td><td colspan="2">Asthma</td><td colspan="2">Eczema</td><td colspan="2">Rhinoconjunctivitis</td></tr><tr><td></td><td>N</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>0.05-3.9</td><td>262</td><td>27</td><td>10.3%</td... |
b31705660248743a89396b54b1beae7442d19ac7d2aab92d37d2ee77a8e76fa6.png | complex | <table><tr><td rowspan="2">Growth Variable</td><td>Exclusively Breastfed (<i>n</i> = 62)</td><td>Exclusively Formula Fed (<i>n</i> = 12)</td><td>Solid Foods with Partial Breastfeeding (<i>n</i> = 57)</td><td>Solid Foods with Formula Feeding (<i>n</i> = 23)</td></tr><tr><td>Mean ± SD</td><td>Mean ± SD</td><td>... | <table><tr><td rowspan="2">Growth Variable</td><td>Exclusively Breastfed (n = 62)</td><td>Exclusively Formula Fed (n = 12)</td><td>Solid Foods with Partial Breastfeeding (n = 57)</td><td>Solid Foods with Formula Feeding (n = 23)</td></tr><tr><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td></tr><... | <table><tr><td rowspan="2">Growth Variable</td><td>Exclusively Breastfed (n = 62)</td><td>Exclusively Formula Fed (n = 12)</td><td>Solid Foods with Partial Breastfeeding (n = 57)</td><td>Solid Foods with Formula Feeding (n = 23)</td></tr><tr><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td></tr><... |
20a2b911780b64213361e46c1338e20fad4953eee37d1e399ebb186e672a24d5.png | simple | <table><tr><td></td><td>NSCLC cases (n = 34)</td><td>Controls (n = 30)</td><td>P-value</td></tr><tr><td>Age</td><td>67.56 (SD 11.12)</td><td>64.48 (SD 11.25)</td><td>0.33</td></tr><tr><td>Sex</td><td></td><td></td><td>0.35</td></tr><tr><td> Female</td><td>10</td><td>9</td><td></td></tr><tr><td> Male</td><td>24</td><td>... | <table><tr><td></td><td>NSCLC cases (n = 34)</td><td>Controls (n = 30)</td><td>P-value</td></tr><tr><td>Age</td><td>67.56 (SD 11.12)</td><td>64.48 (SD 11.25)</td><td>0.33</td></tr><tr><td>Sex</td><td></td><td></td><td>0.35</td></tr><tr><td>Female</td><td>10</td><td>9</td><td></td></tr><tr><td>Male</td><td>24</td><td>21... | <table><tr><td>White</td><td>22</td><td>20</td><td></td></tr><tr><td>African American</td><td>11</td><td>10</td><td></td></tr><tr><td>Pack-years (median)</td><td>34.28</td><td>31.36</td><td>0.32</td></tr><tr><td>Stage</td><td></td><td></td><td></td></tr><tr><td>Stage I</td><td>10</td><td></td><td></td></tr><tr><td>Stag... |
9cf6cf9f46ce62655716c0631cbcf66a33e9dd40c63b688ab3fddb77240f3df7.png | simple | <table><tr><td>Percentile threshold</td><td>Number of ET SNPs</td><td>Number of ET genes</td><td>Number of diseases appropriately distributed among ET populations</td><td>Number of ET genes associated with appropriately distributed diseases</td><td>Permutation <i>P</i> value</td></tr><tr><td>95th/5th</td><td>22</td><td... | <table><tr><td>Percentile threshold</td><td>Number of ET SNPs</td></tr><tr><td>95th/5th</td><td>22</td></tr><tr><td>90th/10th</td><td>168</td></tr><tr><td>85th/15th</td><td>733</td></tr></table> | <table><tr><td>Number of ET genes</td><td>Number of diseases appropriately distributed among ET populations</td><td>Number of ET genes associated with appropriately distributed diseases</td><td>Permutation P value</td></tr><tr><td>33</td><td>6</td><td>4</td><td>0.0237</td></tr><tr><td>230</td><td>27</td><td>15</td><td>... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.